{
  "AIRRKnowledgeCommons": {
    "investigations": {
      "": {
        "akc_id": ""
      },
      "98fcdc94-5d46-4ee3-bfeb-5302b92e33a8": {
        "akc_id": "98fcdc94-5d46-4ee3-bfeb-5302b92e33a8",
        "name": "Yost et al., Clonal replacement of tumor-specific T cells following PD-1 blockade",
        "description": "Paired single-cell RNA and T cell receptor sequencing on 79,046 cells from site-matched tumors from patients with basal or squamous cell carcinoma before and after anti-PD-1 therapy.",
        "study_type": {
          "label": "Study",
          "id": "NCIT:C63536"
        },
        "archival_id": "PRJNA509910",
        "release_date": "2022-10-28T18:45:03.627212+00:00",
        "update_date": "2022-10-28T18:45:03.627212+00:00",
        "participants": [
          "5522592f-e009-479c-b6b7-883d36fe38bb",
          "401e65ca-2ae1-40f4-a803-6893b4315b57",
          "07821645-0f6b-4540-89a0-1543c78411a5",
          "0506a886-caeb-475c-bc87-c020db9404d8",
          "53ce1648-2e3f-4b0f-bad6-dc0fc2df6ec1",
          "e7effb05-28e4-4075-8f80-25afbecd0a45",
          "1b0cf2ae-61fc-4734-aea1-af609544711e",
          "c5f111ae-9d1a-441d-98de-704b487b2912",
          "d9ee04b4-ec17-4354-bc91-8516a8fbf0fa",
          "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70",
          "653c25b5-7212-44f8-ae87-cef2ead98cc3",
          "0b14db2d-2cd6-4402-b02f-ed43b90c1fb5",
          "01186c2c-3394-4a5b-9506-f9612ff5baa3",
          "e524dad6-151b-4743-866f-b5d1eb953d50"
        ],
        "assays": [
          "a3a278d9-5fe0-40c6-ae2d-362af62c6056",
          "baf7043e-df2c-4ae1-b011-493c73de3a09",
          "8745a4fa-6955-4c84-8c53-c10f9b48b5e8",
          "1b50c697-4ab0-451c-890d-44ab109d04f4",
          "9bb1ee3b-809d-41d7-91d5-e780bea86800",
          "efef0977-431b-4fe2-b916-978b24ef80f4",
          "fb698a78-b890-4d33-939f-7f5a838c644f",
          "ce70b727-5feb-46a6-9c46-c854255c9d12",
          "958c43e1-d79a-46fc-a777-332be14713cc",
          "68825c73-637c-408e-abf4-9ba628c135c5",
          "f53be836-cceb-45ee-8eb6-50d1ed38eaf9",
          "ca1c17d6-f2d8-4c46-827f-aeed74f9ed71",
          "8eb7d2da-1ba6-448a-b4cc-5776efa02ff8",
          "f3ecbe9b-7d21-477f-9919-3a600c76f59e",
          "66a5f3a4-51a9-42ef-8546-41062d7c4e51",
          "f73d7990-c922-4e2c-b991-93cad54f7d38",
          "eb6b4ba2-8f18-4e9c-9b83-351203daf69c",
          "d65a88ff-c7c0-4328-8e20-02305b1df34d",
          "d00a99fd-69ea-4a36-83ae-bef5f845aeab",
          "7df34d02-d21f-41d3-ac48-f19360e4bb42",
          "00422f59-9825-4478-a36f-0f0fd3acff87",
          "a391f80f-a660-4bab-9a26-1c49cdca83a0",
          "6b7ca9b5-7795-4065-bbfa-963781a93d55",
          "7109417a-c127-4387-81b5-e0d13909b3a5",
          "4e05db22-636e-47fa-8fe7-7ca8e614959b",
          "6382f77e-bc33-4086-aa80-34c6fee9d846",
          "653a72f3-d92a-4739-ba29-8377efb88463",
          "e927d920-7429-4f14-a70e-fded6d748e33",
          "0dbe19df-4817-4469-8f9a-b685f89d8034",
          "6a86a090-c118-4d30-8e56-cdc40303236b",
          "aae75c35-0a4b-4492-9484-83d0cbd9f603",
          "d147f646-21a9-4774-9b30-3ef895200b15",
          "ef41a822-192e-4c28-83be-5e03466ced65",
          "bb960874-8bb7-4468-9615-4de9bc60b5b1",
          "aad23db0-78d8-49e1-b6f1-aac7a0e8477f",
          "1a5ca97e-1151-4334-a776-7b8cb205609f",
          "34934adc-1cbd-4dab-a053-12c3a78b0fcc",
          "003fa840-3cac-4377-bad8-fd4de27beb03",
          "388aaee5-018c-4274-940c-2a3d2b332337",
          "d129da0a-6f91-4e72-a2ea-c8f8f248f9b5",
          "6f867d88-8756-458f-b31f-75939b8eefd0",
          "640f1d5d-04fd-4a17-8ef0-f55df16c564e",
          "5a0aa911-05a4-45c0-a4ed-e186cab209c8",
          "9350d440-4f2c-49ec-a4f7-7155c7ff5181",
          "79de0aa9-115f-4343-9b23-fa35e3801f90",
          "ca819637-432a-4c2c-9e79-deac273afb39",
          "893b1f3d-c916-456f-bbc7-de2d4c01ceff",
          "fb918c50-1271-43c1-9782-77d5d06896b1",
          "05581d65-18b9-4644-b9e4-7fb14119f349",
          "b17ec252-2d6e-4c46-9be4-16f6454cd450",
          "d7ecadb9-b179-4c99-ad29-9b9bfc3bc92d",
          "98a0dbd4-9e87-475d-968c-7df74d521469",
          "11d5e52d-2b1b-464c-9adf-c26eceb37478",
          "83a041c4-a6e1-4ee1-87f3-39f47e80335d",
          "b066afc1-e0ca-4de9-84c0-7f5587955593",
          "ce17e6da-ff06-4445-af56-9079ef1322e3",
          "fe26404d-ff97-4204-98e1-dcb15b97cb42",
          "c60c7bde-4e59-49b2-b023-b780eb6b0917",
          "06ee50bf-77c8-4dc5-8143-6eea141e026b",
          "f8fa3f94-9fc8-4a7b-bbe4-af703fad8538",
          "02e3e3dc-ac0d-4a69-be58-29f1022aa2e4",
          "232c5f78-b31d-467b-8ca4-4431d23627cc",
          "4262cdab-ac67-491c-88e1-5da27bee86fb",
          "a8609797-be16-4313-83cf-4f25cd519c8e",
          "df75a336-99df-474a-9501-a3264d8215ee",
          "f3d783d7-2547-496b-9ea5-5ebdf72ef9bd",
          "23b3943d-ca31-41eb-bddb-754a6569c1bb",
          "0cf5189f-a218-440f-90d5-ff2cfdf28dba",
          "db558501-855e-4381-ba5b-c21fb5525819",
          "abbff084-7f7a-45b8-b11e-d2cb97eca210",
          "db43d085-e3cc-4f71-b996-bfb5aca5ec9a",
          "f7e351e0-a231-4da3-afb1-80da1f911520",
          "b380aa07-b2ae-4c7b-9c5f-083463fe6e4c",
          "5a98ca4a-9149-4dfc-acb5-f157738b7206",
          "6c4faa8f-ca7b-41c5-9568-89bdd5493b85",
          "7aafb7db-6994-40f8-8fad-c90c302736d6",
          "01f67e22-ffb2-4983-aa47-c4691a4a2a3a",
          "67dc3e29-6fa2-449c-a4c7-bcd7793f3bd9",
          "c377d498-02ab-4d5b-a17d-0380dae76e82",
          "94674cd1-69c3-41a2-9c05-35ae716fb118",
          "b240d624-28b4-4244-89f8-a005f07a56ac",
          "ff74c937-10fe-4f73-b1ba-1686c2db1389",
          "87c48a0e-881d-4fd2-9127-a79b4687d164",
          "5e91a76f-0868-412d-b8f5-61d04c893244",
          "ef5a5840-5653-4e64-9097-ab6db920e975",
          "abde37e0-be0a-4da9-9810-d5f6fa015b1a",
          "d6bc7b13-c581-4921-91b8-2c4db254cd6f",
          "cb4d6889-bc6a-4d4b-ae99-b1e9dfa5b48f",
          "dfa26ecb-b72d-4805-b216-df8086bbc127",
          "74142492-47fa-4827-9874-d44c47a82d90",
          "2770f392-7c90-4ca2-9304-8c7ed45256e2",
          "8663cae6-7f35-49a8-8177-2fa25047d7f4",
          "03e695fa-b1e0-4f57-bb6a-24b9ceb06b61",
          "5bf1822c-fa7c-45ee-8716-d0bde1d2365c",
          "4d20a8de-a680-43d4-b5d3-61f4d7adc863",
          "c230890d-c9b7-4b7e-8aea-112d74b2b6f4",
          "e31effac-20df-417a-bae7-ddb691ed1b74",
          "e6cc12e7-22dc-4e29-af7a-7fce1e9a8b07",
          "45e7ae3e-d851-4e59-9c16-64f771a44df0",
          "d7bb9160-5cea-41e9-9cdf-09635acdd34c",
          "0eb09d2a-13c3-458e-bd02-501f9d58feb1",
          "bef67eff-c1e9-48d5-8342-98ca2f9efac6",
          "31fe33a9-e2d6-485d-896e-020c581c0910",
          "33cac73e-23a3-4e1a-aea6-53752ac51bd5",
          "26975e5b-7c14-41f1-80c0-c1510c445362",
          "d21d2476-543b-45af-b051-43f6435ced65",
          "5a60bbf9-211a-4f8e-868a-8680aaf80cdd",
          "dbcb29d4-de67-494a-918a-09542f3a58fc",
          "c932980c-ded1-4fb4-89d8-1a1d13f443c1",
          "9229ac7f-ba92-4cfd-b1ad-3ff4201f5400",
          "cf47cecb-299e-4d2c-a75a-f30fefd3c1fe",
          "7239c918-5dcf-4d4b-9566-518a76036066",
          "997bb76f-3f99-4b6d-aa94-a45a6efe58d4",
          "a5ad5264-cd6a-4b13-aee5-fb2b001f3eac",
          "ebddc6f2-cc8c-4cb5-9761-848349ac1daa",
          "2c241b57-b90c-4c7d-b7e1-659e38b8967e",
          "0b47e2f6-b3ee-44a8-85d3-6b287ab7f0fd",
          "7edbfa0c-1b5b-426c-b94d-bb26f35f62f5",
          "b49ae668-41eb-45a0-9571-7f945c99b7da",
          "580e6a97-4c92-4098-8cf7-0d69035a7885",
          "639ab9ca-3533-4e4c-bebc-05131597cf12",
          "ef803337-42c6-4156-a031-751edea98b76",
          "6dea779c-faf6-4083-b204-a633f8a20937",
          "d228b810-fc9c-453c-ac9b-cc5fa3ef8a8c",
          "780ae15a-ff05-4e59-9e1d-b8d303ca2385",
          "3e289901-1aa3-4ae2-aad5-2b144f28d13b",
          "933e371b-18d2-41dc-a9c1-9e9d2004c1b0",
          "6ed40141-20a2-4b87-9ba3-46500428cd94",
          "429b2bda-6f0f-4b88-ae93-c5ee1ef0a68f",
          "4ce69db6-95bd-4142-8bef-59d9a909599b",
          "781d722c-4800-4e7b-9044-b551bd2a7a85",
          "7ddb82f9-db9a-456c-a81d-6bb998c85256",
          "cb5210bd-bc8d-48be-973f-d7a66a96efec",
          "4a16dff6-04a6-4b6a-9c60-fbfc902c6329",
          "eb16660e-4a9c-4689-b4b9-2f9935916141",
          "ea745d3c-2453-4cfa-96c5-25d199175a25"
        ],
        "documents": [
          "0c0ee6ec-490b-417b-bae1-dfe264f04ac3"
        ],
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB-CLONE"
        ]
      }
    },
    "references": {
      "0c0ee6ec-490b-417b-bae1-dfe264f04ac3": {
        "source_uri": "",
        "sources": "DOI:10.1038/s41591-019-0522-3",
        "investigations": [
          "",
          "98fcdc94-5d46-4ee3-bfeb-5302b92e33a8"
        ],
        "akc_id": "0c0ee6ec-490b-417b-bae1-dfe264f04ac3",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB-CLONE"
        ]
      }
    },
    "study_arms": {
      "27999847-0a3f-4c6f-ba53-1fe60e7b5414": {
        "akc_id": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "name": "post treatment",
        "investigation": "98fcdc94-5d46-4ee3-bfeb-5302b92e33a8",
        "inclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB-CLONE"
        ]
      },
      "4996f7d3-2589-44fa-a12c-8f63f222c184": {
        "akc_id": "4996f7d3-2589-44fa-a12c-8f63f222c184",
        "name": "pre treatment",
        "investigation": "98fcdc94-5d46-4ee3-bfeb-5302b92e33a8",
        "inclusion_criteria": "include: advanced or metastatic BCC or SCC not suitable for surgical resection; exclude: previous exposure to checkpoint blockade agents and systemic immunosuppressant use, treatment with radiotherapy or other anti-cancer agents within 4 weeks of first biopsy",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB-CLONE"
        ]
      }
    },
    "participants": {
      "5522592f-e009-479c-b6b7-883d36fe38bb": {
        "akc_id": "5522592f-e009-479c-b6b7-883d36fe38bb",
        "name": "su001",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB-CLONE"
        ]
      },
      "401e65ca-2ae1-40f4-a803-6893b4315b57": {
        "akc_id": "401e65ca-2ae1-40f4-a803-6893b4315b57",
        "name": "su002",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB-CLONE"
        ]
      },
      "07821645-0f6b-4540-89a0-1543c78411a5": {
        "akc_id": "07821645-0f6b-4540-89a0-1543c78411a5",
        "name": "su003",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB-CLONE"
        ]
      },
      "0506a886-caeb-475c-bc87-c020db9404d8": {
        "akc_id": "0506a886-caeb-475c-bc87-c020db9404d8",
        "name": "su004",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB-CLONE"
        ]
      },
      "53ce1648-2e3f-4b0f-bad6-dc0fc2df6ec1": {
        "akc_id": "53ce1648-2e3f-4b0f-bad6-dc0fc2df6ec1",
        "name": "su005",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB-CLONE"
        ]
      },
      "e7effb05-28e4-4075-8f80-25afbecd0a45": {
        "akc_id": "e7effb05-28e4-4075-8f80-25afbecd0a45",
        "name": "su006",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB-CLONE"
        ]
      },
      "1b0cf2ae-61fc-4734-aea1-af609544711e": {
        "akc_id": "1b0cf2ae-61fc-4734-aea1-af609544711e",
        "name": "su007",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB-CLONE"
        ]
      },
      "c5f111ae-9d1a-441d-98de-704b487b2912": {
        "akc_id": "c5f111ae-9d1a-441d-98de-704b487b2912",
        "name": "su008",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB-CLONE"
        ]
      },
      "d9ee04b4-ec17-4354-bc91-8516a8fbf0fa": {
        "akc_id": "d9ee04b4-ec17-4354-bc91-8516a8fbf0fa",
        "name": "su009",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB-CLONE"
        ]
      },
      "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70": {
        "akc_id": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70",
        "name": "su010",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE"
        ]
      },
      "653c25b5-7212-44f8-ae87-cef2ead98cc3": {
        "akc_id": "653c25b5-7212-44f8-ae87-cef2ead98cc3",
        "name": "su011",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB-CLONE"
        ]
      },
      "0b14db2d-2cd6-4402-b02f-ed43b90c1fb5": {
        "akc_id": "0b14db2d-2cd6-4402-b02f-ed43b90c1fb5",
        "name": "su012",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB-CLONE"
        ]
      },
      "01186c2c-3394-4a5b-9506-f9612ff5baa3": {
        "akc_id": "01186c2c-3394-4a5b-9506-f9612ff5baa3",
        "name": "su013",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB-CLONE"
        ]
      },
      "e524dad6-151b-4743-866f-b5d1eb953d50": {
        "akc_id": "e524dad6-151b-4743-866f-b5d1eb953d50",
        "name": "su014",
        "study_arm": "27999847-0a3f-4c6f-ba53-1fe60e7b5414",
        "species": {
          "label": "Homo sapiens",
          "id": "NCBITAXON:9606"
        },
        "age": 50,
        "age_unit": {
          "label": "year",
          "id": "UO:0000036"
        },
        "age_event": "sample collection",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB-CLONE"
        ]
      }
    },
    "life_events": {
      "f0e89405-ff11-4812-a783-3aec3f9fdc40": {
        "akc_id": "f0e89405-ff11-4812-a783-3aec3f9fdc40",
        "participant": "5522592f-e009-479c-b6b7-883d36fe38bb"
      },
      "71e984db-823c-4ea7-8aa5-1402694304be": {
        "akc_id": "71e984db-823c-4ea7-8aa5-1402694304be",
        "participant": "5522592f-e009-479c-b6b7-883d36fe38bb"
      },
      "0e9bba3e-fe3c-4d8e-831a-d642130004b4": {
        "akc_id": "0e9bba3e-fe3c-4d8e-831a-d642130004b4",
        "participant": "5522592f-e009-479c-b6b7-883d36fe38bb",
        "t0_event": "post treatment",
        "start": 83,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB-CLONE"
        ]
      },
      "9fef0534-0c1b-4e41-9888-85beb7ba46c9": {
        "akc_id": "9fef0534-0c1b-4e41-9888-85beb7ba46c9",
        "adc_link_tag": "LifeEvent_Participant_su001_su001_pre1",
        "adc_repertoire_id": "PRJNA509910-su001_pre1-TRA",
        "adc_sample_processing_id": "PRJNA509910-su001_pre1-TRA",
        "adc_data_processing_id": "PRJNA509910-su001_pre1",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su001",
        "adc_sample_id": "su001_pre1",
        "adc_study_group_description": "pre treatment",
        "participant": "5522592f-e009-479c-b6b7-883d36fe38bb"
      },
      "308977a5-cc92-4d21-9ca4-d949cce9092e": {
        "akc_id": "308977a5-cc92-4d21-9ca4-d949cce9092e",
        "participant": "5522592f-e009-479c-b6b7-883d36fe38bb",
        "t0_event": "pre treatment",
        "start": 239,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB-CLONE"
        ]
      },
      "fb67bd68-3469-454a-9079-309c1aa76d75": {
        "akc_id": "fb67bd68-3469-454a-9079-309c1aa76d75",
        "adc_link_tag": "LifeEvent_Participant_su001_su001_pre2",
        "adc_repertoire_id": "PRJNA509910-su001_pre2-TRA",
        "adc_sample_processing_id": "PRJNA509910-su001_pre2-TRA",
        "adc_data_processing_id": "PRJNA509910-su001_pre2",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su001",
        "adc_sample_id": "su001_pre2",
        "adc_study_group_description": "pre treatment",
        "participant": "5522592f-e009-479c-b6b7-883d36fe38bb"
      },
      "581cd3a3-f761-4775-8ae8-7e82b3ac23f2": {
        "akc_id": "581cd3a3-f761-4775-8ae8-7e82b3ac23f2",
        "participant": "5522592f-e009-479c-b6b7-883d36fe38bb",
        "t0_event": "pre treatment",
        "start": 78,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB-CLONE"
        ]
      },
      "31e83f8e-c0a7-4881-a6ce-8ab85b204691": {
        "akc_id": "31e83f8e-c0a7-4881-a6ce-8ab85b204691",
        "participant": "401e65ca-2ae1-40f4-a803-6893b4315b57"
      },
      "d34dd411-dab1-4732-ae32-122c35a2a6b0": {
        "akc_id": "d34dd411-dab1-4732-ae32-122c35a2a6b0",
        "participant": "401e65ca-2ae1-40f4-a803-6893b4315b57"
      },
      "db0bcbcf-3444-4923-802c-1fed9c9021fd": {
        "akc_id": "db0bcbcf-3444-4923-802c-1fed9c9021fd",
        "participant": "401e65ca-2ae1-40f4-a803-6893b4315b57",
        "t0_event": "post treatment",
        "start": 62,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB-CLONE"
        ]
      },
      "1ca4d209-b1e8-4128-a0bf-f28fe960dc5b": {
        "akc_id": "1ca4d209-b1e8-4128-a0bf-f28fe960dc5b",
        "adc_link_tag": "LifeEvent_Participant_su002_su002_pre",
        "adc_repertoire_id": "PRJNA509910-su002_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su002_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su002_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su002",
        "adc_sample_id": "su002_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "401e65ca-2ae1-40f4-a803-6893b4315b57"
      },
      "5f6f36c7-d750-410c-8a04-d1cea993de22": {
        "akc_id": "5f6f36c7-d750-410c-8a04-d1cea993de22",
        "participant": "401e65ca-2ae1-40f4-a803-6893b4315b57",
        "t0_event": "pre treatment",
        "start": 0,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB-CLONE"
        ]
      },
      "7c0af4ba-bc83-4857-9f4f-0caad9b4c819": {
        "akc_id": "7c0af4ba-bc83-4857-9f4f-0caad9b4c819",
        "participant": "07821645-0f6b-4540-89a0-1543c78411a5"
      },
      "638420de-95e3-417e-8f75-7125cadf7390": {
        "akc_id": "638420de-95e3-417e-8f75-7125cadf7390",
        "participant": "07821645-0f6b-4540-89a0-1543c78411a5"
      },
      "97b4ab10-ecd4-421c-8341-7a3049b0938e": {
        "akc_id": "97b4ab10-ecd4-421c-8341-7a3049b0938e",
        "participant": "07821645-0f6b-4540-89a0-1543c78411a5",
        "t0_event": "post treatment",
        "start": 16,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB-CLONE"
        ]
      },
      "f6cef3c2-b5d6-4a3e-ab04-8fe8400eee27": {
        "akc_id": "f6cef3c2-b5d6-4a3e-ab04-8fe8400eee27",
        "adc_link_tag": "LifeEvent_Participant_su003_su003_pre",
        "adc_repertoire_id": "PRJNA509910-su003_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su003_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su003_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su003",
        "adc_sample_id": "su003_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "07821645-0f6b-4540-89a0-1543c78411a5"
      },
      "1cb64f55-d4b6-4a84-88d6-b2960440a87c": {
        "akc_id": "1cb64f55-d4b6-4a84-88d6-b2960440a87c",
        "participant": "07821645-0f6b-4540-89a0-1543c78411a5",
        "t0_event": "pre treatment",
        "start": 243,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB-CLONE"
        ]
      },
      "0e97b404-9d5f-4f1d-a7b0-1167c4fb16a5": {
        "akc_id": "0e97b404-9d5f-4f1d-a7b0-1167c4fb16a5",
        "participant": "0506a886-caeb-475c-bc87-c020db9404d8"
      },
      "da89eb85-c9f3-4303-a6d6-43e5595d08c7": {
        "akc_id": "da89eb85-c9f3-4303-a6d6-43e5595d08c7",
        "participant": "0506a886-caeb-475c-bc87-c020db9404d8"
      },
      "0e7cf52d-f9e9-4953-bdec-5fb7ff214b05": {
        "akc_id": "0e7cf52d-f9e9-4953-bdec-5fb7ff214b05",
        "participant": "0506a886-caeb-475c-bc87-c020db9404d8",
        "t0_event": "post treatment",
        "start": 38,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB-CLONE"
        ]
      },
      "d592023c-c629-4d61-8f92-99e3fa78f56c": {
        "akc_id": "d592023c-c629-4d61-8f92-99e3fa78f56c",
        "adc_link_tag": "LifeEvent_Participant_su004_su004_pre",
        "adc_repertoire_id": "PRJNA509910-su004_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su004_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su004_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su004",
        "adc_sample_id": "su004_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "0506a886-caeb-475c-bc87-c020db9404d8"
      },
      "d422b1e3-fe32-405e-8ab4-60ccbe4c2814": {
        "akc_id": "d422b1e3-fe32-405e-8ab4-60ccbe4c2814",
        "participant": "0506a886-caeb-475c-bc87-c020db9404d8",
        "t0_event": "pre treatment",
        "start": 1,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB-CLONE"
        ]
      },
      "7e311ccd-1390-41f3-80b1-78143a2427ab": {
        "akc_id": "7e311ccd-1390-41f3-80b1-78143a2427ab",
        "participant": "53ce1648-2e3f-4b0f-bad6-dc0fc2df6ec1"
      },
      "65b4163b-fa94-4f36-b055-59e48ef3db13": {
        "akc_id": "65b4163b-fa94-4f36-b055-59e48ef3db13",
        "participant": "53ce1648-2e3f-4b0f-bad6-dc0fc2df6ec1"
      },
      "7d46cacf-32f5-4238-8feb-3b357d4d0100": {
        "akc_id": "7d46cacf-32f5-4238-8feb-3b357d4d0100",
        "participant": "53ce1648-2e3f-4b0f-bad6-dc0fc2df6ec1",
        "t0_event": "post treatment",
        "start": 105,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB-CLONE"
        ]
      },
      "d2dbce60-3570-49c7-b684-f9ed40f9c16c": {
        "akc_id": "d2dbce60-3570-49c7-b684-f9ed40f9c16c",
        "adc_link_tag": "LifeEvent_Participant_su005_su005_pre",
        "adc_repertoire_id": "PRJNA509910-su005_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su005_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su005_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su005",
        "adc_sample_id": "su005_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "53ce1648-2e3f-4b0f-bad6-dc0fc2df6ec1"
      },
      "19823f62-0da4-4f8f-b8dd-85e0f00b9229": {
        "akc_id": "19823f62-0da4-4f8f-b8dd-85e0f00b9229",
        "participant": "53ce1648-2e3f-4b0f-bad6-dc0fc2df6ec1",
        "t0_event": "pre treatment",
        "start": 0,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB-CLONE"
        ]
      },
      "76e4cfe1-27b9-4514-89d3-443d08c4ad5e": {
        "akc_id": "76e4cfe1-27b9-4514-89d3-443d08c4ad5e",
        "participant": "e7effb05-28e4-4075-8f80-25afbecd0a45"
      },
      "d412405f-5539-4702-8ccf-08b4167d8d26": {
        "akc_id": "d412405f-5539-4702-8ccf-08b4167d8d26",
        "participant": "e7effb05-28e4-4075-8f80-25afbecd0a45"
      },
      "df68c24c-27af-4eba-9ad6-c22ebe7c4973": {
        "akc_id": "df68c24c-27af-4eba-9ad6-c22ebe7c4973",
        "participant": "e7effb05-28e4-4075-8f80-25afbecd0a45",
        "t0_event": "post treatment",
        "start": 21,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB-CLONE"
        ]
      },
      "dbde0aae-c79d-4770-b0a3-d64f60d93431": {
        "akc_id": "dbde0aae-c79d-4770-b0a3-d64f60d93431",
        "adc_link_tag": "LifeEvent_Participant_su006_su006_pre",
        "adc_repertoire_id": "PRJNA509910-su006_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su006_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su006_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su006",
        "adc_sample_id": "su006_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "e7effb05-28e4-4075-8f80-25afbecd0a45"
      },
      "45cc988b-884a-45fe-b18a-c657670e2aab": {
        "akc_id": "45cc988b-884a-45fe-b18a-c657670e2aab",
        "participant": "e7effb05-28e4-4075-8f80-25afbecd0a45",
        "t0_event": "pre treatment",
        "start": 0,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB-CLONE"
        ]
      },
      "9b7c092c-b1dc-453e-b098-3bb4a08170b2": {
        "akc_id": "9b7c092c-b1dc-453e-b098-3bb4a08170b2",
        "participant": "1b0cf2ae-61fc-4734-aea1-af609544711e"
      },
      "b320af5f-6392-4c00-bf5e-224bf9ba2d5f": {
        "akc_id": "b320af5f-6392-4c00-bf5e-224bf9ba2d5f",
        "participant": "1b0cf2ae-61fc-4734-aea1-af609544711e"
      },
      "516db0c7-4756-4ee8-ab6d-91e67d83b3ab": {
        "akc_id": "516db0c7-4756-4ee8-ab6d-91e67d83b3ab",
        "participant": "1b0cf2ae-61fc-4734-aea1-af609544711e",
        "t0_event": "post treatment",
        "start": 60,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB-CLONE"
        ]
      },
      "7bc5f9f8-9f5d-4cad-a994-50ac0299c535": {
        "akc_id": "7bc5f9f8-9f5d-4cad-a994-50ac0299c535",
        "adc_link_tag": "LifeEvent_Participant_su007_su007_pre",
        "adc_repertoire_id": "PRJNA509910-su007_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su007_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su007_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su007",
        "adc_sample_id": "su007_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "1b0cf2ae-61fc-4734-aea1-af609544711e"
      },
      "d3c447f0-921f-4691-956c-2ff30554abc2": {
        "akc_id": "d3c447f0-921f-4691-956c-2ff30554abc2",
        "participant": "1b0cf2ae-61fc-4734-aea1-af609544711e",
        "t0_event": "pre treatment",
        "start": 3,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB-CLONE"
        ]
      },
      "714f4931-fb99-430b-a80d-9f93531302ef": {
        "akc_id": "714f4931-fb99-430b-a80d-9f93531302ef",
        "participant": "c5f111ae-9d1a-441d-98de-704b487b2912"
      },
      "d3450571-5fdc-491b-8a8f-a58bb1f5cdd3": {
        "akc_id": "d3450571-5fdc-491b-8a8f-a58bb1f5cdd3",
        "participant": "c5f111ae-9d1a-441d-98de-704b487b2912"
      },
      "58349663-3fa9-4073-900e-ef75b4d0b182": {
        "akc_id": "58349663-3fa9-4073-900e-ef75b4d0b182",
        "participant": "c5f111ae-9d1a-441d-98de-704b487b2912",
        "t0_event": "post treatment",
        "start": 43,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB-CLONE"
        ]
      },
      "a91e7bd2-257e-4db4-b4a3-afe7e83c4239": {
        "akc_id": "a91e7bd2-257e-4db4-b4a3-afe7e83c4239",
        "adc_link_tag": "LifeEvent_Participant_su008_su008_pre",
        "adc_repertoire_id": "PRJNA509910-su008_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su008_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su008_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su008",
        "adc_sample_id": "su008_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "c5f111ae-9d1a-441d-98de-704b487b2912"
      },
      "650adbc1-d840-4513-a513-05f5bf176e88": {
        "akc_id": "650adbc1-d840-4513-a513-05f5bf176e88",
        "participant": "c5f111ae-9d1a-441d-98de-704b487b2912",
        "t0_event": "pre treatment",
        "start": 91,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB-CLONE"
        ]
      },
      "29aa9785-8725-416f-ab8c-19ed1a5ce7c9": {
        "akc_id": "29aa9785-8725-416f-ab8c-19ed1a5ce7c9",
        "participant": "d9ee04b4-ec17-4354-bc91-8516a8fbf0fa"
      },
      "83fab8fd-1605-40f8-8a19-3d5bb0259cf9": {
        "akc_id": "83fab8fd-1605-40f8-8a19-3d5bb0259cf9",
        "participant": "d9ee04b4-ec17-4354-bc91-8516a8fbf0fa"
      },
      "56562e88-943b-447a-b3e9-865bbf17df46": {
        "akc_id": "56562e88-943b-447a-b3e9-865bbf17df46",
        "participant": "d9ee04b4-ec17-4354-bc91-8516a8fbf0fa",
        "t0_event": "post treatment",
        "start": 21,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB-CLONE"
        ]
      },
      "c1763047-651e-494e-be5e-4ec0e0818b00": {
        "akc_id": "c1763047-651e-494e-be5e-4ec0e0818b00",
        "adc_link_tag": "LifeEvent_Participant_su009_su009_pre",
        "adc_repertoire_id": "PRJNA509910-su009_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su009_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su009_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su009",
        "adc_sample_id": "su009_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "d9ee04b4-ec17-4354-bc91-8516a8fbf0fa"
      },
      "46671cdf-301a-4279-bf14-6008b42e1263": {
        "akc_id": "46671cdf-301a-4279-bf14-6008b42e1263",
        "participant": "d9ee04b4-ec17-4354-bc91-8516a8fbf0fa",
        "t0_event": "pre treatment",
        "start": 0,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB-CLONE"
        ]
      },
      "8e09e4f7-63ec-4da6-a098-a1a02944c3f1": {
        "akc_id": "8e09e4f7-63ec-4da6-a098-a1a02944c3f1",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70"
      },
      "cb055a14-8067-4dc2-8a29-cf550972edd9": {
        "akc_id": "cb055a14-8067-4dc2-8a29-cf550972edd9",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70"
      },
      "65f075e0-bc9f-482c-bcfd-989693a31f04": {
        "akc_id": "65f075e0-bc9f-482c-bcfd-989693a31f04",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70",
        "t0_event": "post treatment",
        "start": 21,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB-CLONE"
        ]
      },
      "25012be7-e1df-4d06-b385-e034d1f56847": {
        "akc_id": "25012be7-e1df-4d06-b385-e034d1f56847",
        "adc_link_tag": "LifeEvent_Participant_su010_su010_post_SCC",
        "adc_repertoire_id": "PRJNA509910-su010_post_SCC-TRA",
        "adc_sample_processing_id": "PRJNA509910-su010_post_SCC-TRA",
        "adc_data_processing_id": "PRJNA509910-su010_post_SCC",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su010",
        "adc_sample_id": "su010_post_SCC",
        "adc_study_group_description": "post treatment",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70"
      },
      "907bc5aa-8b55-4b66-9501-5b1de1fd7816": {
        "akc_id": "907bc5aa-8b55-4b66-9501-5b1de1fd7816",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70"
      },
      "9353fadc-8b9b-4153-8c8c-0256010bc966": {
        "akc_id": "9353fadc-8b9b-4153-8c8c-0256010bc966",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70",
        "t0_event": "post treatment",
        "start": 21,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB-CLONE"
        ]
      },
      "49cd118a-be8b-4420-ac3c-ef4c9670f907": {
        "akc_id": "49cd118a-be8b-4420-ac3c-ef4c9670f907",
        "adc_link_tag": "LifeEvent_Participant_su010_su010_post_SCC_CD39",
        "adc_repertoire_id": "PRJNA509910-su010_post_SCC_CD39-TRA",
        "adc_sample_processing_id": "PRJNA509910-su010_post_SCC_CD39-TRA",
        "adc_data_processing_id": "PRJNA509910-su010_post_SCC_CD39",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su010",
        "adc_sample_id": "su010_post_SCC_CD39",
        "adc_study_group_description": "post treatment",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70"
      },
      "4aac5c94-e7fc-4d1a-8a62-c1d2f554f460": {
        "akc_id": "4aac5c94-e7fc-4d1a-8a62-c1d2f554f460",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70",
        "t0_event": "post treatment",
        "start": 21,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB-CLONE"
        ]
      },
      "a5f08e84-ac4c-4642-8570-46070204106d": {
        "akc_id": "a5f08e84-ac4c-4642-8570-46070204106d",
        "adc_link_tag": "LifeEvent_Participant_su010_su010_pre_BCC",
        "adc_repertoire_id": "PRJNA509910-su010_pre_BCC-TRA",
        "adc_sample_processing_id": "PRJNA509910-su010_pre_BCC-TRA",
        "adc_data_processing_id": "PRJNA509910-su010_pre_BCC",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su010",
        "adc_sample_id": "su010_pre_BCC",
        "adc_study_group_description": "pre treatment",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70"
      },
      "92307fc9-9c0b-4329-98df-173c91cc4c8c": {
        "akc_id": "92307fc9-9c0b-4329-98df-173c91cc4c8c",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70",
        "t0_event": "pre treatment",
        "start": 6,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB-CLONE"
        ]
      },
      "15ab8713-062d-4175-bd3b-9ef9a9bcaeb1": {
        "akc_id": "15ab8713-062d-4175-bd3b-9ef9a9bcaeb1",
        "adc_link_tag": "LifeEvent_Participant_su010_su010_pre_SCC_rep1",
        "adc_repertoire_id": "PRJNA509910-su010_pre_SCC_rep1-TRA",
        "adc_sample_processing_id": "PRJNA509910-su010_pre_SCC_rep1-TRA",
        "adc_data_processing_id": "PRJNA509910-su010_pre_SCC_rep1",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su010",
        "adc_sample_id": "su010_pre_SCC_rep1",
        "adc_study_group_description": "pre treatment",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70"
      },
      "8101a7fb-a7bc-4dd3-8217-5e0b8f59639b": {
        "akc_id": "8101a7fb-a7bc-4dd3-8217-5e0b8f59639b",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70",
        "t0_event": "pre treatment",
        "start": 6,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE"
        ]
      },
      "307a188c-d2ea-4701-b2cb-c6c94012c71e": {
        "akc_id": "307a188c-d2ea-4701-b2cb-c6c94012c71e",
        "adc_link_tag": "LifeEvent_Participant_su010_su010_pre_SCC_rep2",
        "adc_repertoire_id": "PRJNA509910-su010_pre_SCC_rep2-TRA",
        "adc_sample_processing_id": "PRJNA509910-su010_pre_SCC_rep2-TRA",
        "adc_data_processing_id": "PRJNA509910-su010_pre_SCC_rep2",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su010",
        "adc_sample_id": "su010_pre_SCC_rep2",
        "adc_study_group_description": "pre treatment",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70"
      },
      "3d5fe643-ab86-4f40-80d8-f2e571ef32ac": {
        "akc_id": "3d5fe643-ab86-4f40-80d8-f2e571ef32ac",
        "participant": "1d7f6f89-c42d-4a07-8ac6-a5c7a3378d70",
        "t0_event": "pre treatment",
        "start": 6,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE"
        ]
      },
      "c2bd5c63-b692-4d35-88fd-e996ba0f4667": {
        "akc_id": "c2bd5c63-b692-4d35-88fd-e996ba0f4667",
        "participant": "653c25b5-7212-44f8-ae87-cef2ead98cc3"
      },
      "82dd1f38-3844-4148-91f1-355c6bf0e422": {
        "akc_id": "82dd1f38-3844-4148-91f1-355c6bf0e422",
        "participant": "653c25b5-7212-44f8-ae87-cef2ead98cc3"
      },
      "3e12942b-df03-492c-a1e9-6679d9b2e69e": {
        "akc_id": "3e12942b-df03-492c-a1e9-6679d9b2e69e",
        "participant": "653c25b5-7212-44f8-ae87-cef2ead98cc3",
        "t0_event": "post treatment",
        "start": 29,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB-CLONE"
        ]
      },
      "c83fcdc1-bd9d-4aae-8e05-944002ed1d42": {
        "akc_id": "c83fcdc1-bd9d-4aae-8e05-944002ed1d42",
        "adc_link_tag": "LifeEvent_Participant_su011_su011_pre_rep1",
        "adc_repertoire_id": "PRJNA509910-su011_pre_rep1-TRA",
        "adc_sample_processing_id": "PRJNA509910-su011_pre_rep1-TRA",
        "adc_data_processing_id": "PRJNA509910-su011_pre_rep1",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su011",
        "adc_sample_id": "su011_pre_rep1",
        "adc_study_group_description": "pre treatment",
        "participant": "653c25b5-7212-44f8-ae87-cef2ead98cc3"
      },
      "328a7bb4-0c66-450e-8549-df72e6dd2f54": {
        "akc_id": "328a7bb4-0c66-450e-8549-df72e6dd2f54",
        "participant": "653c25b5-7212-44f8-ae87-cef2ead98cc3",
        "t0_event": "pre treatment",
        "start": 13,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB-CLONE"
        ]
      },
      "00bfad73-858f-4378-84f9-63304cac65b8": {
        "akc_id": "00bfad73-858f-4378-84f9-63304cac65b8",
        "adc_link_tag": "LifeEvent_Participant_su011_su011_pre_rep2",
        "adc_repertoire_id": "PRJNA509910-su011_pre_rep2-TRA",
        "adc_sample_processing_id": "PRJNA509910-su011_pre_rep2-TRA",
        "adc_data_processing_id": "PRJNA509910-su011_pre_rep2",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su011",
        "adc_sample_id": "su011_pre_rep2",
        "adc_study_group_description": "pre treatment",
        "participant": "653c25b5-7212-44f8-ae87-cef2ead98cc3"
      },
      "b4da9bea-40fe-4b0d-89c5-08ee8bbd501f": {
        "akc_id": "b4da9bea-40fe-4b0d-89c5-08ee8bbd501f",
        "participant": "653c25b5-7212-44f8-ae87-cef2ead98cc3",
        "t0_event": "pre treatment",
        "start": 13,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB-CLONE"
        ]
      },
      "1e2593ea-cc4a-44aa-8fc9-a7a444871dfe": {
        "akc_id": "1e2593ea-cc4a-44aa-8fc9-a7a444871dfe",
        "participant": "0b14db2d-2cd6-4402-b02f-ed43b90c1fb5"
      },
      "6b301f9d-69be-4142-85e9-e04cc6994212": {
        "akc_id": "6b301f9d-69be-4142-85e9-e04cc6994212",
        "participant": "0b14db2d-2cd6-4402-b02f-ed43b90c1fb5"
      },
      "049e9859-f4ff-4ee7-a050-ecade4d96835": {
        "akc_id": "049e9859-f4ff-4ee7-a050-ecade4d96835",
        "participant": "0b14db2d-2cd6-4402-b02f-ed43b90c1fb5",
        "t0_event": "post treatment",
        "start": 21,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB-CLONE"
        ]
      },
      "3fc39e33-a5c2-4f5f-98ab-d426ad4f1b5e": {
        "akc_id": "3fc39e33-a5c2-4f5f-98ab-d426ad4f1b5e",
        "adc_link_tag": "LifeEvent_Participant_su012_su012_pre",
        "adc_repertoire_id": "PRJNA509910-su012_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su012_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su012_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su012",
        "adc_sample_id": "su012_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "0b14db2d-2cd6-4402-b02f-ed43b90c1fb5"
      },
      "524d0be2-ed50-4687-ba2b-52c217d95439": {
        "akc_id": "524d0be2-ed50-4687-ba2b-52c217d95439",
        "participant": "0b14db2d-2cd6-4402-b02f-ed43b90c1fb5",
        "t0_event": "pre treatment",
        "start": 0,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB-CLONE"
        ]
      },
      "2103b9f5-692f-4e12-9558-ab6fff038ec7": {
        "akc_id": "2103b9f5-692f-4e12-9558-ab6fff038ec7",
        "participant": "01186c2c-3394-4a5b-9506-f9612ff5baa3"
      },
      "8c75c615-1815-4f77-8927-31d109e82e92": {
        "akc_id": "8c75c615-1815-4f77-8927-31d109e82e92",
        "participant": "01186c2c-3394-4a5b-9506-f9612ff5baa3"
      },
      "5ccc71d1-48ff-4b02-ada4-ab9f95cf7b59": {
        "akc_id": "5ccc71d1-48ff-4b02-ada4-ab9f95cf7b59",
        "participant": "01186c2c-3394-4a5b-9506-f9612ff5baa3",
        "t0_event": "post treatment",
        "start": 49,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB-CLONE"
        ]
      },
      "4455a8af-a432-4cfa-88ce-e85a400ebe42": {
        "akc_id": "4455a8af-a432-4cfa-88ce-e85a400ebe42",
        "adc_link_tag": "LifeEvent_Participant_su013_su013_pre",
        "adc_repertoire_id": "PRJNA509910-su013_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su013_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su013_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su013",
        "adc_sample_id": "su013_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "01186c2c-3394-4a5b-9506-f9612ff5baa3"
      },
      "39be9b53-4661-4552-bb1b-a306306c4d61": {
        "akc_id": "39be9b53-4661-4552-bb1b-a306306c4d61",
        "participant": "01186c2c-3394-4a5b-9506-f9612ff5baa3",
        "t0_event": "pre treatment",
        "start": 7,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB-CLONE"
        ]
      },
      "aa68bdf9-2b1e-4b6c-b160-6111fa82ab80": {
        "akc_id": "aa68bdf9-2b1e-4b6c-b160-6111fa82ab80",
        "participant": "e524dad6-151b-4743-866f-b5d1eb953d50"
      },
      "97f9c1f4-c5d7-451b-952e-a25372039862": {
        "akc_id": "97f9c1f4-c5d7-451b-952e-a25372039862",
        "participant": "e524dad6-151b-4743-866f-b5d1eb953d50"
      },
      "99e4a953-2638-4069-8d4e-9a7662212bb0": {
        "akc_id": "99e4a953-2638-4069-8d4e-9a7662212bb0",
        "participant": "e524dad6-151b-4743-866f-b5d1eb953d50",
        "t0_event": "post treatment",
        "start": 28,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB-CLONE"
        ]
      },
      "ad8a5a90-41f3-495a-9d33-88711ee309b1": {
        "akc_id": "ad8a5a90-41f3-495a-9d33-88711ee309b1",
        "adc_link_tag": "LifeEvent_Participant_su014_su014_pre",
        "adc_repertoire_id": "PRJNA509910-su014_pre-TRA",
        "adc_sample_processing_id": "PRJNA509910-su014_pre-TRA",
        "adc_data_processing_id": "PRJNA509910-su014_pre",
        "adc_study_id": "PRJNA509910",
        "adc_subject_id": "su014",
        "adc_sample_id": "su014_pre",
        "adc_study_group_description": "pre treatment",
        "participant": "e524dad6-151b-4743-866f-b5d1eb953d50"
      },
      "d89cb2f5-acb2-4de0-b8db-42ecf58506d3": {
        "akc_id": "d89cb2f5-acb2-4de0-b8db-42ecf58506d3",
        "participant": "e524dad6-151b-4743-866f-b5d1eb953d50",
        "t0_event": "pre treatment",
        "start": 0,
        "time_unit": {
          "label": "day",
          "id": "UO:0000033"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB-CLONE"
        ]
      }
    },
    "immune_exposures": {
      "568a8ebf-bec7-46a2-b805-e461c489e391": {
        "akc_id": "568a8ebf-bec7-46a2-b805-e461c489e391",
        "life_event": "71e984db-823c-4ea7-8aa5-1402694304be",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB-CLONE"
        ]
      },
      "4a1919fa-8d36-4e73-bc81-abd55ae3dd08": {
        "akc_id": "4a1919fa-8d36-4e73-bc81-abd55ae3dd08",
        "life_event": "d34dd411-dab1-4732-ae32-122c35a2a6b0",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB-CLONE"
        ]
      },
      "37719f80-4ff5-45bb-a0ae-2c7c6bfe4795": {
        "akc_id": "37719f80-4ff5-45bb-a0ae-2c7c6bfe4795",
        "life_event": "638420de-95e3-417e-8f75-7125cadf7390",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB-CLONE"
        ]
      },
      "b24ad49f-6c9e-4093-8616-2ea6176a5439": {
        "akc_id": "b24ad49f-6c9e-4093-8616-2ea6176a5439",
        "life_event": "da89eb85-c9f3-4303-a6d6-43e5595d08c7",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB-CLONE"
        ]
      },
      "917cb260-aa76-4b69-a255-805f79fb4b75": {
        "akc_id": "917cb260-aa76-4b69-a255-805f79fb4b75",
        "life_event": "65b4163b-fa94-4f36-b055-59e48ef3db13",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB-CLONE"
        ]
      },
      "79772517-828c-4701-b32c-a901dd364ac4": {
        "akc_id": "79772517-828c-4701-b32c-a901dd364ac4",
        "life_event": "d412405f-5539-4702-8ccf-08b4167d8d26",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB-CLONE"
        ]
      },
      "a0be5a2f-e841-4d3a-b8fb-bf40fb436825": {
        "akc_id": "a0be5a2f-e841-4d3a-b8fb-bf40fb436825",
        "life_event": "b320af5f-6392-4c00-bf5e-224bf9ba2d5f",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB-CLONE"
        ]
      },
      "c5831886-9568-449b-8fe4-267776b056cb": {
        "akc_id": "c5831886-9568-449b-8fe4-267776b056cb",
        "life_event": "d3450571-5fdc-491b-8a8f-a58bb1f5cdd3",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB-CLONE"
        ]
      },
      "f42a0f2e-d70d-469e-bbd9-1c1bf4c27293": {
        "akc_id": "f42a0f2e-d70d-469e-bbd9-1c1bf4c27293",
        "life_event": "83fab8fd-1605-40f8-8a19-3d5bb0259cf9",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB-CLONE"
        ]
      },
      "a4638f74-8bc2-4328-88a5-5081153dd799": {
        "akc_id": "a4638f74-8bc2-4328-88a5-5081153dd799",
        "life_event": "cb055a14-8067-4dc2-8a29-cf550972edd9",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB-CLONE"
        ]
      },
      "afb69984-3844-470c-91c2-89ebfe50005a": {
        "akc_id": "afb69984-3844-470c-91c2-89ebfe50005a",
        "life_event": "907bc5aa-8b55-4b66-9501-5b1de1fd7816",
        "disease": {
          "label": "squamous cell carcinoma",
          "id": "DOID:1749"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE"
        ]
      },
      "e9b50a27-3d50-4db0-b90d-cde1d9df8643": {
        "akc_id": "e9b50a27-3d50-4db0-b90d-cde1d9df8643",
        "life_event": "82dd1f38-3844-4148-91f1-355c6bf0e422",
        "disease": {
          "label": "squamous cell carcinoma",
          "id": "DOID:1749"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB-CLONE"
        ]
      },
      "41caa1d7-3e78-4466-b6b2-37ab626c77ce": {
        "akc_id": "41caa1d7-3e78-4466-b6b2-37ab626c77ce",
        "life_event": "6b301f9d-69be-4142-85e9-e04cc6994212",
        "disease": {
          "label": "basal cell carcinoma",
          "id": "DOID:2513"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB-CLONE"
        ]
      },
      "47979e39-16da-40c7-86bf-f04908865c38": {
        "akc_id": "47979e39-16da-40c7-86bf-f04908865c38",
        "life_event": "8c75c615-1815-4f77-8927-31d109e82e92",
        "disease": {
          "label": "squamous cell carcinoma",
          "id": "DOID:1749"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB-CLONE"
        ]
      },
      "02f750be-1cc6-4e47-b1bb-774499559f35": {
        "akc_id": "02f750be-1cc6-4e47-b1bb-774499559f35",
        "life_event": "97f9c1f4-c5d7-451b-952e-a25372039862",
        "disease": {
          "label": "squamous cell carcinoma",
          "id": "DOID:1749"
        },
        "disease_stage": "advanced/metastatic",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB-CLONE",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB-CLONE"
        ]
      }
    },
    "specimens": {
      "92d9b519-9164-4997-aad8-7ef13bbcfb98": {
        "akc_id": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "name": "su001_post",
        "life_event": "0e9bba3e-fe3c-4d8e-831a-d642130004b4",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "arm skin",
          "id": "UBERON:0002427"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB-CLONE"
        ]
      },
      "aae16c00-d11c-41a4-a00e-a3cc8189ad25": {
        "akc_id": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "name": "su001_pre1",
        "life_event": "308977a5-cc92-4d21-9ca4-d949cce9092e",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "arm skin",
          "id": "UBERON:0002427"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB-CLONE"
        ]
      },
      "b6d90c5e-65c8-4613-b84f-2f7899988db4": {
        "akc_id": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "name": "su001_pre2",
        "life_event": "581cd3a3-f761-4775-8ae8-7e82b3ac23f2",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "arm skin",
          "id": "UBERON:0002427"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB-CLONE"
        ]
      },
      "55221162-6222-4812-83a1-692a57ff70cb": {
        "akc_id": "55221162-6222-4812-83a1-692a57ff70cb",
        "name": "su002_post",
        "life_event": "db0bcbcf-3444-4923-802c-1fed9c9021fd",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "nose skin",
          "id": "UBERON:0015476"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB-CLONE"
        ]
      },
      "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1": {
        "akc_id": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "name": "su002_pre",
        "life_event": "5f6f36c7-d750-410c-8a04-d1cea993de22",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "nose skin",
          "id": "UBERON:0015476"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB-CLONE"
        ]
      },
      "7cbf2f3b-a809-45da-918e-442156b1094c": {
        "akc_id": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "name": "su003_post",
        "life_event": "97b4ab10-ecd4-421c-8341-7a3049b0938e",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of chest",
          "id": "UBERON:0001868"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB-CLONE"
        ]
      },
      "25b68ff4-3141-4407-8f0b-bae28b8c6c65": {
        "akc_id": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "name": "su003_pre",
        "life_event": "1cb64f55-d4b6-4a84-88d6-b2960440a87c",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "arm skin",
          "id": "UBERON:0002427"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB-CLONE"
        ]
      },
      "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d": {
        "akc_id": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "name": "su004_post",
        "life_event": "0e7cf52d-f9e9-4953-bdec-5fb7ff214b05",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of knee",
          "id": "UBERON:0001510"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB-CLONE"
        ]
      },
      "038dad3c-51e4-4bce-ba89-19225bb007a6": {
        "akc_id": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "name": "su004_pre",
        "life_event": "d422b1e3-fe32-405e-8ab4-60ccbe4c2814",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of knee",
          "id": "UBERON:0001510"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB-CLONE"
        ]
      },
      "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c": {
        "akc_id": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "name": "su005_post",
        "life_event": "7d46cacf-32f5-4238-8feb-3b357d4d0100",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of external ear",
          "id": "UBERON:0001459"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB-CLONE"
        ]
      },
      "fba0fb98-21ab-4236-bc95-28afa9331d1b": {
        "akc_id": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "name": "su005_pre",
        "life_event": "19823f62-0da4-4f8f-b8dd-85e0f00b9229",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of external ear",
          "id": "UBERON:0001459"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB-CLONE"
        ]
      },
      "78a36f69-1d49-4b0f-bcb9-d844669e53de": {
        "akc_id": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "name": "su006_post",
        "life_event": "df68c24c-27af-4eba-9ad6-c22ebe7c4973",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of neck",
          "id": "UBERON:0001417"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB-CLONE"
        ]
      },
      "435f4efc-51ae-4755-b910-96b229feed70": {
        "akc_id": "435f4efc-51ae-4755-b910-96b229feed70",
        "name": "su006_pre",
        "life_event": "45cc988b-884a-45fe-b18a-c657670e2aab",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of neck",
          "id": "UBERON:0001417"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB-CLONE"
        ]
      },
      "a6596eb2-9c22-4362-8d40-148f6a92eb77": {
        "akc_id": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "name": "su007_post",
        "life_event": "516db0c7-4756-4ee8-ab6d-91e67d83b3ab",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of cheek",
          "id": "UBERON:0008803"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB-CLONE"
        ]
      },
      "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5": {
        "akc_id": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "name": "su007_pre",
        "life_event": "d3c447f0-921f-4691-956c-2ff30554abc2",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of cheek",
          "id": "UBERON:0008803"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB-CLONE"
        ]
      },
      "d9067d60-21f3-4026-9eca-757b3ce3ef6b": {
        "akc_id": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "name": "su008_post",
        "life_event": "58349663-3fa9-4073-900e-ef75b4d0b182",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "arm skin",
          "id": "UBERON:0002427"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB-CLONE"
        ]
      },
      "1c2493af-1e3f-462e-93a5-fbd8030c9aec": {
        "akc_id": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "name": "su008_pre",
        "life_event": "650adbc1-d840-4513-a513-05f5bf176e88",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "arm skin",
          "id": "UBERON:0002427"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB-CLONE"
        ]
      },
      "5b27e569-e307-45c9-bee6-84d7d695790c": {
        "akc_id": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "name": "su009_post",
        "life_event": "56562e88-943b-447a-b3e9-865bbf17df46",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of forehead",
          "id": "UBERON:0016475"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB-CLONE"
        ]
      },
      "c46e236c-65de-41a2-9b46-4aa67163e957": {
        "akc_id": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "name": "su009_pre",
        "life_event": "46671cdf-301a-4279-bf14-6008b42e1263",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of forehead",
          "id": "UBERON:0016475"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB-CLONE"
        ]
      },
      "e2aba60b-1a13-4605-a3b5-b767aba262b0": {
        "akc_id": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "name": "su010_post_BCC",
        "life_event": "65f075e0-bc9f-482c-bcfd-989693a31f04",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "lower leg skin",
          "id": "UBERON:0004264"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB-CLONE"
        ]
      },
      "25548f5a-485c-48f8-a86e-fb3a91f48302": {
        "akc_id": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "name": "su010_post_SCC",
        "life_event": "9353fadc-8b9b-4153-8c8c-0256010bc966",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of external ear",
          "id": "UBERON:0001459"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB-CLONE"
        ]
      },
      "b79ab136-1b28-43df-8127-f010833c0ad7": {
        "akc_id": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "name": "su010_post_SCC_CD39",
        "life_event": "4aac5c94-e7fc-4d1a-8a62-c1d2f554f460",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of external ear",
          "id": "UBERON:0001459"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB-CLONE"
        ]
      },
      "914281f3-349e-49ed-ad79-b936ffb285a0": {
        "akc_id": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "name": "su010_pre_BCC",
        "life_event": "92307fc9-9c0b-4329-98df-173c91cc4c8c",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "lower leg skin",
          "id": "UBERON:0004264"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB-CLONE"
        ]
      },
      "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc": {
        "akc_id": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "name": "su010_pre_SCC_rep1",
        "life_event": "8101a7fb-a7bc-4dd3-8217-5e0b8f59639b",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of external ear",
          "id": "UBERON:0001459"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE"
        ]
      },
      "29b69431-9d47-452d-a6b0-dd5d570368d9": {
        "akc_id": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "name": "su010_pre_SCC_rep2",
        "life_event": "3d5fe643-ab86-4f40-80d8-f2e571ef32ac",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of external ear",
          "id": "UBERON:0001459"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE"
        ]
      },
      "a3605308-9342-4be1-be8c-d090d4c0cf1b": {
        "akc_id": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "name": "su011_post",
        "life_event": "3e12942b-df03-492c-a1e9-6679d9b2e69e",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of scalp",
          "id": "UBERON:8300000"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB-CLONE"
        ]
      },
      "7d5e6a0d-5e2e-4c7c-9039-dce172c75376": {
        "akc_id": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "name": "su011_pre_rep1",
        "life_event": "328a7bb4-0c66-450e-8549-df72e6dd2f54",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of scalp",
          "id": "UBERON:8300000"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB-CLONE"
        ]
      },
      "8a1f1002-8b38-4053-a203-73af2cf7c499": {
        "akc_id": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "name": "su011_pre_rep2",
        "life_event": "b4da9bea-40fe-4b0d-89c5-08ee8bbd501f",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of scalp",
          "id": "UBERON:8300000"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB-CLONE"
        ]
      },
      "119b69ad-ea8f-4145-8211-71eccbbcde4b": {
        "akc_id": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "name": "su012_post",
        "life_event": "049e9859-f4ff-4ee7-a050-ecade4d96835",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of cheek",
          "id": "UBERON:0008803"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB-CLONE"
        ]
      },
      "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d": {
        "akc_id": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "name": "su012_pre",
        "life_event": "524d0be2-ed50-4687-ba2b-52c217d95439",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of cheek",
          "id": "UBERON:0008803"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB-CLONE"
        ]
      },
      "098f12b0-f535-45d9-a248-af22f3cddd5b": {
        "akc_id": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "name": "su013_post",
        "life_event": "5ccc71d1-48ff-4b02-ada4-ab9f95cf7b59",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of scalp",
          "id": "UBERON:8300000"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB-CLONE"
        ]
      },
      "cebbf35a-4838-4001-b9af-27f3da23ab76": {
        "akc_id": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "name": "su013_pre",
        "life_event": "39be9b53-4661-4552-bb1b-a306306c4d61",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of scalp",
          "id": "UBERON:8300000"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB-CLONE"
        ]
      },
      "8775cdd8-827c-46c9-b205-76f530f9bcf2": {
        "akc_id": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "name": "su014_post",
        "life_event": "99e4a953-2638-4069-8d4e-9a7662212bb0",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of neck",
          "id": "UBERON:0001417"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB-CLONE"
        ]
      },
      "b20f015a-51d4-4cee-956e-25af251e44bc": {
        "akc_id": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "name": "su014_pre",
        "life_event": "d89cb2f5-acb2-4de0-b8db-42ecf58506d3",
        "specimen_type": "biopsy",
        "tissue": {
          "label": "skin of neck",
          "id": "UBERON:0001417"
        },
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRA",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-CELL",
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB-CLONE"
        ]
      }
    },
    "specimen_processings": {
      "4d27bc99-ddf4-461c-8918-a6c0757992a2": {
        "akc_id": "4d27bc99-ddf4-461c-8918-a6c0757992a2",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3773,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRA"
        ]
      },
      "d048e56c-9791-4588-810b-5ffab4e3fe03": {
        "akc_id": "d048e56c-9791-4588-810b-5ffab4e3fe03",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRA"
        ]
      },
      "4541c467-e145-41ca-99cd-db8350519fad": {
        "akc_id": "4541c467-e145-41ca-99cd-db8350519fad",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRA"
        ]
      },
      "1980a854-037b-4eb6-81da-81e1ffe75aa7": {
        "akc_id": "1980a854-037b-4eb6-81da-81e1ffe75aa7",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3773,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB"
        ]
      },
      "e0b5fc46-fbfb-42ca-8a4d-39af7f316e1b": {
        "akc_id": "e0b5fc46-fbfb-42ca-8a4d-39af7f316e1b",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB"
        ]
      },
      "73a14b0d-8263-47a1-a804-1c8d27588b40": {
        "akc_id": "73a14b0d-8263-47a1-a804-1c8d27588b40",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB"
        ]
      },
      "aeb5c143-8674-48f0-b5b1-87bdfd74e79c": {
        "akc_id": "aeb5c143-8674-48f0-b5b1-87bdfd74e79c",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4915,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-CELL"
        ]
      },
      "e94c3091-23e2-41df-81eb-732da3adc5c9": {
        "akc_id": "e94c3091-23e2-41df-81eb-732da3adc5c9",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-CELL"
        ]
      },
      "929c4bdd-2b33-4452-a158-5fc412f44154": {
        "akc_id": "929c4bdd-2b33-4452-a158-5fc412f44154",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-CELL"
        ]
      },
      "09e96fa3-7e64-4d09-b6c5-4e72ff6af792": {
        "akc_id": "09e96fa3-7e64-4d09-b6c5-4e72ff6af792",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3773,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB-CLONE"
        ]
      },
      "5fdaceb6-f5eb-4997-8447-f329e6e5b9cf": {
        "akc_id": "5fdaceb6-f5eb-4997-8447-f329e6e5b9cf",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB-CLONE"
        ]
      },
      "7392c9c9-e201-48bc-9df5-f46bfa4dee13": {
        "akc_id": "7392c9c9-e201-48bc-9df5-f46bfa4dee13",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB-CLONE"
        ]
      },
      "7bdaba50-e3fb-4812-bc2f-d9b164ed7a9b": {
        "akc_id": "7bdaba50-e3fb-4812-bc2f-d9b164ed7a9b",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 700,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRA"
        ]
      },
      "ce7ba865-2d19-402f-9c5c-513a9db9c376": {
        "akc_id": "ce7ba865-2d19-402f-9c5c-513a9db9c376",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRA"
        ]
      },
      "3279fcb5-c2a8-4046-8c62-af30e1a59def": {
        "akc_id": "3279fcb5-c2a8-4046-8c62-af30e1a59def",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRA"
        ]
      },
      "04087fef-e7ad-4432-a43f-7640cd7eaa59": {
        "akc_id": "04087fef-e7ad-4432-a43f-7640cd7eaa59",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 700,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB"
        ]
      },
      "7eb26e17-03c1-4c50-a427-ee9f23d681a6": {
        "akc_id": "7eb26e17-03c1-4c50-a427-ee9f23d681a6",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB"
        ]
      },
      "c6e7adb5-39f4-4b40-92b4-d352b2baa9e8": {
        "akc_id": "c6e7adb5-39f4-4b40-92b4-d352b2baa9e8",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB"
        ]
      },
      "aa902947-4ee5-48a3-b45f-cb860a205b24": {
        "akc_id": "aa902947-4ee5-48a3-b45f-cb860a205b24",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 975,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-CELL"
        ]
      },
      "a55ff175-b7c8-4f01-83de-ce931275029f": {
        "akc_id": "a55ff175-b7c8-4f01-83de-ce931275029f",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-CELL"
        ]
      },
      "87f43232-0863-4d9d-81c8-579228c90bed": {
        "akc_id": "87f43232-0863-4d9d-81c8-579228c90bed",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-CELL"
        ]
      },
      "d92cd9f5-d619-4944-ad18-9908ffed5dd9": {
        "akc_id": "d92cd9f5-d619-4944-ad18-9908ffed5dd9",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 700,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB-CLONE"
        ]
      },
      "ef77c268-d268-4322-9ee7-d3199d74f1d0": {
        "akc_id": "ef77c268-d268-4322-9ee7-d3199d74f1d0",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB-CLONE"
        ]
      },
      "9ae58be7-385f-4545-b2e6-bfffbdf0766a": {
        "akc_id": "9ae58be7-385f-4545-b2e6-bfffbdf0766a",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB-CLONE"
        ]
      },
      "23115f04-cda6-42ad-ba9e-82dabfef0682": {
        "akc_id": "23115f04-cda6-42ad-ba9e-82dabfef0682",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 106,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRA"
        ]
      },
      "0e24797e-13ce-40c3-aa66-5002dea285ec": {
        "akc_id": "0e24797e-13ce-40c3-aa66-5002dea285ec",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRA"
        ]
      },
      "8e47629e-b4f2-444d-bc41-e3371fa1a97c": {
        "akc_id": "8e47629e-b4f2-444d-bc41-e3371fa1a97c",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRA"
        ]
      },
      "47f265b4-9f59-4fe2-b1f9-5558a9c5b8d2": {
        "akc_id": "47f265b4-9f59-4fe2-b1f9-5558a9c5b8d2",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 106,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB"
        ]
      },
      "9feb7386-5cea-424a-82f8-4928202dda17": {
        "akc_id": "9feb7386-5cea-424a-82f8-4928202dda17",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB"
        ]
      },
      "fa45e217-caf6-40ac-896b-11d88abbae84": {
        "akc_id": "fa45e217-caf6-40ac-896b-11d88abbae84",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB"
        ]
      },
      "b9550c89-d0e8-41bf-b677-c257e207e9b9": {
        "akc_id": "b9550c89-d0e8-41bf-b677-c257e207e9b9",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 192,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-CELL"
        ]
      },
      "4ac60953-7ca6-4533-ac98-0bfdd4c104e8": {
        "akc_id": "4ac60953-7ca6-4533-ac98-0bfdd4c104e8",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-CELL"
        ]
      },
      "43c4ac1a-6ba4-4725-bade-f06e3df426cb": {
        "akc_id": "43c4ac1a-6ba4-4725-bade-f06e3df426cb",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-CELL"
        ]
      },
      "1e9e0753-b490-4d83-a5cb-a7a6ae207efa": {
        "akc_id": "1e9e0753-b490-4d83-a5cb-a7a6ae207efa",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 106,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB-CLONE"
        ]
      },
      "e8a0ab6d-207c-4068-a043-8f0eb2b069de": {
        "akc_id": "e8a0ab6d-207c-4068-a043-8f0eb2b069de",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB-CLONE"
        ]
      },
      "44ddee54-d6af-42db-ad55-e55c65716d22": {
        "akc_id": "44ddee54-d6af-42db-ad55-e55c65716d22",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB-CLONE"
        ]
      },
      "ad42e38a-f5e3-4c39-8916-4a00d594b236": {
        "akc_id": "ad42e38a-f5e3-4c39-8916-4a00d594b236",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 147,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRA"
        ]
      },
      "7feb475f-f77f-400c-8bdd-206f258b20f7": {
        "akc_id": "7feb475f-f77f-400c-8bdd-206f258b20f7",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRA"
        ]
      },
      "4fae1d9d-9fdd-4d99-84cd-1b7786668ff9": {
        "akc_id": "4fae1d9d-9fdd-4d99-84cd-1b7786668ff9",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRA"
        ]
      },
      "8ca21761-606b-4b27-9fd5-cffe9759819a": {
        "akc_id": "8ca21761-606b-4b27-9fd5-cffe9759819a",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 147,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB"
        ]
      },
      "3ba76b4f-cff0-4280-88dd-7b6920ab5873": {
        "akc_id": "3ba76b4f-cff0-4280-88dd-7b6920ab5873",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB"
        ]
      },
      "4e0828e4-62d3-4a5c-9e70-6b9531ecc3d4": {
        "akc_id": "4e0828e4-62d3-4a5c-9e70-6b9531ecc3d4",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB"
        ]
      },
      "ce1d005b-f739-45b8-b05e-950f7e05be1a": {
        "akc_id": "ce1d005b-f739-45b8-b05e-950f7e05be1a",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 195,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-CELL"
        ]
      },
      "a5d02998-a362-47a6-9746-1d0abfef2085": {
        "akc_id": "a5d02998-a362-47a6-9746-1d0abfef2085",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-CELL"
        ]
      },
      "65e5a67e-6a47-4305-abdd-0c39c4334924": {
        "akc_id": "65e5a67e-6a47-4305-abdd-0c39c4334924",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-CELL"
        ]
      },
      "90b1136a-e535-4c63-b8c3-f0e179712b5d": {
        "akc_id": "90b1136a-e535-4c63-b8c3-f0e179712b5d",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 147,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB-CLONE"
        ]
      },
      "812df8e2-fb8c-407e-82ec-a2a4b8a01507": {
        "akc_id": "812df8e2-fb8c-407e-82ec-a2a4b8a01507",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB-CLONE"
        ]
      },
      "296d02bb-7d4a-4ca5-b6a4-7a92dac0047a": {
        "akc_id": "296d02bb-7d4a-4ca5-b6a4-7a92dac0047a",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB-CLONE"
        ]
      },
      "c00d100e-6e8b-4dcf-8fd4-aac6d6f5bbc2": {
        "akc_id": "c00d100e-6e8b-4dcf-8fd4-aac6d6f5bbc2",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 81,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRA"
        ]
      },
      "36a971a4-5094-406f-acc4-590d92448027": {
        "akc_id": "36a971a4-5094-406f-acc4-590d92448027",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRA"
        ]
      },
      "3bacea64-7201-470e-9c71-a19dab539c47": {
        "akc_id": "3bacea64-7201-470e-9c71-a19dab539c47",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRA"
        ]
      },
      "fa0d50bc-d094-4e9a-8b64-dd1aaf74186b": {
        "akc_id": "fa0d50bc-d094-4e9a-8b64-dd1aaf74186b",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 81,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB"
        ]
      },
      "9d5ab258-229f-41c0-9fef-32e097d6fd41": {
        "akc_id": "9d5ab258-229f-41c0-9fef-32e097d6fd41",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB"
        ]
      },
      "df72a697-90a6-420b-9414-daac7858e5f2": {
        "akc_id": "df72a697-90a6-420b-9414-daac7858e5f2",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB"
        ]
      },
      "b2f55084-7a21-4097-b83c-c0310c3fa7cf": {
        "akc_id": "b2f55084-7a21-4097-b83c-c0310c3fa7cf",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 162,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-CELL"
        ]
      },
      "6b103956-0da4-43c3-b29a-4cbca511f0e1": {
        "akc_id": "6b103956-0da4-43c3-b29a-4cbca511f0e1",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-CELL"
        ]
      },
      "f360c1eb-214c-4ffc-b6e1-3d9d3fd6d07b": {
        "akc_id": "f360c1eb-214c-4ffc-b6e1-3d9d3fd6d07b",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-CELL"
        ]
      },
      "a3bcb679-ef11-4745-8333-55626b145396": {
        "akc_id": "a3bcb679-ef11-4745-8333-55626b145396",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 81,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB-CLONE"
        ]
      },
      "65772e42-2150-4aca-90e5-b7458dac44af": {
        "akc_id": "65772e42-2150-4aca-90e5-b7458dac44af",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB-CLONE"
        ]
      },
      "15d9fbaf-3ea4-40a6-8622-96a8ac145fec": {
        "akc_id": "15d9fbaf-3ea4-40a6-8622-96a8ac145fec",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB-CLONE"
        ]
      },
      "c0f37f53-d6bb-487d-bd4d-57f4392c39aa": {
        "akc_id": "c0f37f53-d6bb-487d-bd4d-57f4392c39aa",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 114,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRA"
        ]
      },
      "39c287fd-ea6d-428e-a1ab-c3f254b754a3": {
        "akc_id": "39c287fd-ea6d-428e-a1ab-c3f254b754a3",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRA"
        ]
      },
      "f334766f-01bb-4295-875b-f8a6aee9f571": {
        "akc_id": "f334766f-01bb-4295-875b-f8a6aee9f571",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRA"
        ]
      },
      "c96c0994-b1eb-4486-b0c5-496609876bc9": {
        "akc_id": "c96c0994-b1eb-4486-b0c5-496609876bc9",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 114,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB"
        ]
      },
      "b6f462d7-cf9d-4d43-a369-e87ec6e88b99": {
        "akc_id": "b6f462d7-cf9d-4d43-a369-e87ec6e88b99",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB"
        ]
      },
      "bab7e739-8565-48bb-a4f4-1ef1473f3a2c": {
        "akc_id": "bab7e739-8565-48bb-a4f4-1ef1473f3a2c",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB"
        ]
      },
      "66a342a3-e152-4cc3-9def-78368b110c12": {
        "akc_id": "66a342a3-e152-4cc3-9def-78368b110c12",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 262,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-CELL"
        ]
      },
      "9e7a74a4-0f46-4756-a2a6-847668a54fe9": {
        "akc_id": "9e7a74a4-0f46-4756-a2a6-847668a54fe9",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-CELL"
        ]
      },
      "cb3d2ec8-5dde-41de-9d16-2b9dde6658f3": {
        "akc_id": "cb3d2ec8-5dde-41de-9d16-2b9dde6658f3",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-CELL"
        ]
      },
      "ef7f292d-fdc7-4c32-b9f1-765e735acca0": {
        "akc_id": "ef7f292d-fdc7-4c32-b9f1-765e735acca0",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 114,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB-CLONE"
        ]
      },
      "1b9707b0-c0b9-4b6a-9d3d-071b61e1cb87": {
        "akc_id": "1b9707b0-c0b9-4b6a-9d3d-071b61e1cb87",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB-CLONE"
        ]
      },
      "ef9787ce-8013-4572-b81c-abbfcb499cb1": {
        "akc_id": "ef9787ce-8013-4572-b81c-abbfcb499cb1",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB-CLONE"
        ]
      },
      "d7217bdd-f00d-47b4-ad1b-43bf35acffca": {
        "akc_id": "d7217bdd-f00d-47b4-ad1b-43bf35acffca",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 73,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRA"
        ]
      },
      "31510efb-c0e8-407d-85fb-1e48448801e5": {
        "akc_id": "31510efb-c0e8-407d-85fb-1e48448801e5",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRA"
        ]
      },
      "68356df6-74cf-4fcd-b36a-55f86f8a21ac": {
        "akc_id": "68356df6-74cf-4fcd-b36a-55f86f8a21ac",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRA"
        ]
      },
      "2aa87486-ae93-4b1b-9792-1cd023f901e6": {
        "akc_id": "2aa87486-ae93-4b1b-9792-1cd023f901e6",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 73,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB"
        ]
      },
      "6f008267-e697-4a85-9611-c0a5af4750cd": {
        "akc_id": "6f008267-e697-4a85-9611-c0a5af4750cd",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB"
        ]
      },
      "eaee54fd-1c6c-481c-baa6-2527ac572d59": {
        "akc_id": "eaee54fd-1c6c-481c-baa6-2527ac572d59",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB"
        ]
      },
      "cf2edf15-55ca-4d74-ab91-27ccdf4446ca": {
        "akc_id": "cf2edf15-55ca-4d74-ab91-27ccdf4446ca",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 329,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-CELL"
        ]
      },
      "fa5506b3-3ab9-4b77-bef1-3a30102206cd": {
        "akc_id": "fa5506b3-3ab9-4b77-bef1-3a30102206cd",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-CELL"
        ]
      },
      "0f0ca87a-da8a-417b-90dc-20082aff8e65": {
        "akc_id": "0f0ca87a-da8a-417b-90dc-20082aff8e65",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-CELL"
        ]
      },
      "d59456cc-9dba-4655-8319-07144cfc49eb": {
        "akc_id": "d59456cc-9dba-4655-8319-07144cfc49eb",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 73,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB-CLONE"
        ]
      },
      "23350383-a571-45c9-9469-8ac1feaf4242": {
        "akc_id": "23350383-a571-45c9-9469-8ac1feaf4242",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB-CLONE"
        ]
      },
      "fafc8817-ee2e-4f2a-bb17-bffec1c58611": {
        "akc_id": "fafc8817-ee2e-4f2a-bb17-bffec1c58611",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB-CLONE"
        ]
      },
      "020ff1f2-2d6e-4461-973b-f30a69bc0114": {
        "akc_id": "020ff1f2-2d6e-4461-973b-f30a69bc0114",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 295,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRA"
        ]
      },
      "80ba433d-b49e-4fab-b7a3-1c312c231347": {
        "akc_id": "80ba433d-b49e-4fab-b7a3-1c312c231347",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRA"
        ]
      },
      "8db7ea15-c78a-4074-b294-915a2609385d": {
        "akc_id": "8db7ea15-c78a-4074-b294-915a2609385d",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRA"
        ]
      },
      "0e2f3722-1cc3-4b62-80a3-65ff58b6ec44": {
        "akc_id": "0e2f3722-1cc3-4b62-80a3-65ff58b6ec44",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 295,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB"
        ]
      },
      "32cd8760-9640-4212-88f5-ef67d08516b5": {
        "akc_id": "32cd8760-9640-4212-88f5-ef67d08516b5",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB"
        ]
      },
      "78e3abc7-99e7-4e02-877c-edf30dd6147e": {
        "akc_id": "78e3abc7-99e7-4e02-877c-edf30dd6147e",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB"
        ]
      },
      "49d43319-8b2c-437d-8705-3d68a0364ae1": {
        "akc_id": "49d43319-8b2c-437d-8705-3d68a0364ae1",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 400,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-CELL"
        ]
      },
      "7dc9f59c-20e0-43ae-a0b4-f2ac348242c7": {
        "akc_id": "7dc9f59c-20e0-43ae-a0b4-f2ac348242c7",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-CELL"
        ]
      },
      "a112308c-91cc-41b9-9006-37bafd6f4d4b": {
        "akc_id": "a112308c-91cc-41b9-9006-37bafd6f4d4b",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-CELL"
        ]
      },
      "65c10d12-4784-4681-9021-4849ec75fc61": {
        "akc_id": "65c10d12-4784-4681-9021-4849ec75fc61",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 295,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB-CLONE"
        ]
      },
      "1e160d42-0361-49db-9b1b-5fd62a97a5ab": {
        "akc_id": "1e160d42-0361-49db-9b1b-5fd62a97a5ab",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB-CLONE"
        ]
      },
      "45a2fa01-0f58-43ea-bcd9-1466b1fe65a6": {
        "akc_id": "45a2fa01-0f58-43ea-bcd9-1466b1fe65a6",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB-CLONE"
        ]
      },
      "32a3cf4b-5778-4fe4-9e36-041391f6a2a0": {
        "akc_id": "32a3cf4b-5778-4fe4-9e36-041391f6a2a0",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 471,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRA"
        ]
      },
      "4b6f2427-5b0a-4096-a758-1b5193e9dc65": {
        "akc_id": "4b6f2427-5b0a-4096-a758-1b5193e9dc65",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRA"
        ]
      },
      "8601eb32-f43a-4156-a85a-2344c7034c26": {
        "akc_id": "8601eb32-f43a-4156-a85a-2344c7034c26",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRA"
        ]
      },
      "b98304df-08c0-44f2-9e5d-bee95a2ff18d": {
        "akc_id": "b98304df-08c0-44f2-9e5d-bee95a2ff18d",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 471,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB"
        ]
      },
      "a24809cb-f4c7-465b-b96a-cb68a3d2fff7": {
        "akc_id": "a24809cb-f4c7-465b-b96a-cb68a3d2fff7",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB"
        ]
      },
      "4977c329-d14c-4853-8321-0ac0e0bde2e4": {
        "akc_id": "4977c329-d14c-4853-8321-0ac0e0bde2e4",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB"
        ]
      },
      "2d2e6e35-a9aa-4f0d-94b3-3ec036d54fab": {
        "akc_id": "2d2e6e35-a9aa-4f0d-94b3-3ec036d54fab",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 661,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-CELL"
        ]
      },
      "3ba9d1b3-9642-4cf3-b9c9-dbd1256d9581": {
        "akc_id": "3ba9d1b3-9642-4cf3-b9c9-dbd1256d9581",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-CELL"
        ]
      },
      "55b1b274-a411-4498-8cd7-2f5ba2c36de3": {
        "akc_id": "55b1b274-a411-4498-8cd7-2f5ba2c36de3",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-CELL"
        ]
      },
      "b131836c-8164-4d34-b80c-65baef838f0d": {
        "akc_id": "b131836c-8164-4d34-b80c-65baef838f0d",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 471,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB-CLONE"
        ]
      },
      "eb80f884-c1e7-41d1-9eae-30381fc8457c": {
        "akc_id": "eb80f884-c1e7-41d1-9eae-30381fc8457c",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB-CLONE"
        ]
      },
      "d0ca6c2c-0247-4453-b269-7d04e131bd3d": {
        "akc_id": "d0ca6c2c-0247-4453-b269-7d04e131bd3d",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB-CLONE"
        ]
      },
      "146ee476-a38f-470a-8bac-ad05ecaafea5": {
        "akc_id": "146ee476-a38f-470a-8bac-ad05ecaafea5",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3859,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRA"
        ]
      },
      "949777f7-cc49-4d64-b214-38a431e4b14c": {
        "akc_id": "949777f7-cc49-4d64-b214-38a431e4b14c",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRA"
        ]
      },
      "57ffb4db-d9dd-4b85-9e52-b9bdc0fffebc": {
        "akc_id": "57ffb4db-d9dd-4b85-9e52-b9bdc0fffebc",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRA"
        ]
      },
      "f379f1c9-5ce9-4420-a9d6-2dcde1b1918a": {
        "akc_id": "f379f1c9-5ce9-4420-a9d6-2dcde1b1918a",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3859,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB"
        ]
      },
      "76b18f4b-d15a-45f2-969e-f72d95c73bb3": {
        "akc_id": "76b18f4b-d15a-45f2-969e-f72d95c73bb3",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB"
        ]
      },
      "9dcf4e64-7514-4754-8cf0-47dd9d10baa9": {
        "akc_id": "9dcf4e64-7514-4754-8cf0-47dd9d10baa9",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB"
        ]
      },
      "d89920f2-6791-4ff2-8c35-e52da76a8328": {
        "akc_id": "d89920f2-6791-4ff2-8c35-e52da76a8328",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4870,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-CELL"
        ]
      },
      "54059cb5-e2a2-44fb-afd2-133529a0f6c4": {
        "akc_id": "54059cb5-e2a2-44fb-afd2-133529a0f6c4",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-CELL"
        ]
      },
      "1d195e8c-9cd8-4649-9a67-cdfae753c7a9": {
        "akc_id": "1d195e8c-9cd8-4649-9a67-cdfae753c7a9",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-CELL"
        ]
      },
      "75aaa76b-ae30-478b-8cab-79ce3070ad67": {
        "akc_id": "75aaa76b-ae30-478b-8cab-79ce3070ad67",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3859,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB-CLONE"
        ]
      },
      "a49e1dd8-c853-49af-82b4-544993c169ba": {
        "akc_id": "a49e1dd8-c853-49af-82b4-544993c169ba",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB-CLONE"
        ]
      },
      "eea6ecdf-cc3f-4476-baff-5b05bbb1116b": {
        "akc_id": "eea6ecdf-cc3f-4476-baff-5b05bbb1116b",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB-CLONE"
        ]
      },
      "129de834-8874-4f9a-b696-e81e0a9c071a": {
        "akc_id": "129de834-8874-4f9a-b696-e81e0a9c071a",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 839,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRA"
        ]
      },
      "b0b7c94a-33d6-4be5-88d2-10e468795bcf": {
        "akc_id": "b0b7c94a-33d6-4be5-88d2-10e468795bcf",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRA"
        ]
      },
      "4f153ed1-72d3-47c7-96a6-410d0f345f4d": {
        "akc_id": "4f153ed1-72d3-47c7-96a6-410d0f345f4d",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRA"
        ]
      },
      "8b6f62f2-59a7-4124-b23e-64cd54d0069b": {
        "akc_id": "8b6f62f2-59a7-4124-b23e-64cd54d0069b",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 839,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB"
        ]
      },
      "d9f5be01-6d95-40ed-a4ef-c68b0e190300": {
        "akc_id": "d9f5be01-6d95-40ed-a4ef-c68b0e190300",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB"
        ]
      },
      "fdf08b81-7d46-470e-8394-4c895baa832a": {
        "akc_id": "fdf08b81-7d46-470e-8394-4c895baa832a",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB"
        ]
      },
      "d0a8cf47-252d-4a98-9dcf-f4f588d8f457": {
        "akc_id": "d0a8cf47-252d-4a98-9dcf-f4f588d8f457",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1134,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-CELL"
        ]
      },
      "c0c06b6d-9603-4017-b25f-2bed2069d97a": {
        "akc_id": "c0c06b6d-9603-4017-b25f-2bed2069d97a",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-CELL"
        ]
      },
      "3ff61409-b53d-46c4-ab8d-75210621c33e": {
        "akc_id": "3ff61409-b53d-46c4-ab8d-75210621c33e",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-CELL"
        ]
      },
      "a93bf906-996b-4a94-a579-f3bf14f59f08": {
        "akc_id": "a93bf906-996b-4a94-a579-f3bf14f59f08",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 839,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB-CLONE"
        ]
      },
      "c6de30f8-bfe7-4f89-b065-157118b8ed85": {
        "akc_id": "c6de30f8-bfe7-4f89-b065-157118b8ed85",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB-CLONE"
        ]
      },
      "780b4cbd-3320-437b-ad3b-41f2ad0770b1": {
        "akc_id": "780b4cbd-3320-437b-ad3b-41f2ad0770b1",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB-CLONE"
        ]
      },
      "133c86e7-0956-4d7a-b392-2fc439df079c": {
        "akc_id": "133c86e7-0956-4d7a-b392-2fc439df079c",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1784,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRA"
        ]
      },
      "0d68b33d-c448-4ae9-838a-384774dbe5d7": {
        "akc_id": "0d68b33d-c448-4ae9-838a-384774dbe5d7",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRA"
        ]
      },
      "0cfaca4d-7ca4-43df-a47e-1b10243fb2f6": {
        "akc_id": "0cfaca4d-7ca4-43df-a47e-1b10243fb2f6",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRA"
        ]
      },
      "1ce9b0d4-ab94-4af2-bee4-ada6329a7b42": {
        "akc_id": "1ce9b0d4-ab94-4af2-bee4-ada6329a7b42",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1784,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB"
        ]
      },
      "306db7a8-248b-4d52-92e2-2dc4610d802c": {
        "akc_id": "306db7a8-248b-4d52-92e2-2dc4610d802c",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB"
        ]
      },
      "db48a82f-4696-4d65-9b87-89c8554fd545": {
        "akc_id": "db48a82f-4696-4d65-9b87-89c8554fd545",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB"
        ]
      },
      "4868459f-a5ce-433e-94fe-f7202bffcf4d": {
        "akc_id": "4868459f-a5ce-433e-94fe-f7202bffcf4d",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2034,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-CELL"
        ]
      },
      "82d6d637-28a7-4963-8dcf-26b6da7d669b": {
        "akc_id": "82d6d637-28a7-4963-8dcf-26b6da7d669b",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-CELL"
        ]
      },
      "64436296-7303-4897-97b9-b22503444d83": {
        "akc_id": "64436296-7303-4897-97b9-b22503444d83",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-CELL"
        ]
      },
      "1548ab7d-9f60-409d-b651-dfe973d36fbe": {
        "akc_id": "1548ab7d-9f60-409d-b651-dfe973d36fbe",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1784,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB-CLONE"
        ]
      },
      "2b351111-1592-4a96-b62e-18cf3a2178c6": {
        "akc_id": "2b351111-1592-4a96-b62e-18cf3a2178c6",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB-CLONE"
        ]
      },
      "c675d862-217c-483a-b7c2-a8755a43a9d0": {
        "akc_id": "c675d862-217c-483a-b7c2-a8755a43a9d0",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB-CLONE"
        ]
      },
      "01a99e49-d65c-4c0d-a67a-efbda653371b": {
        "akc_id": "01a99e49-d65c-4c0d-a67a-efbda653371b",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2220,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRA"
        ]
      },
      "a080b26e-6b63-40e6-9d23-dbeb66762542": {
        "akc_id": "a080b26e-6b63-40e6-9d23-dbeb66762542",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRA"
        ]
      },
      "6d6715dc-3816-4ddb-aa3a-917cd86d49fa": {
        "akc_id": "6d6715dc-3816-4ddb-aa3a-917cd86d49fa",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRA"
        ]
      },
      "b87c83e8-0b0f-459d-b1f4-5525d7e9aeec": {
        "akc_id": "b87c83e8-0b0f-459d-b1f4-5525d7e9aeec",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2220,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB"
        ]
      },
      "b211bfe1-1379-4df9-8708-3f0412bc2150": {
        "akc_id": "b211bfe1-1379-4df9-8708-3f0412bc2150",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB"
        ]
      },
      "939dff07-fe51-49fa-bf06-be8c97815b96": {
        "akc_id": "939dff07-fe51-49fa-bf06-be8c97815b96",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB"
        ]
      },
      "255c44f7-0734-4a97-a088-7c0036aaca31": {
        "akc_id": "255c44f7-0734-4a97-a088-7c0036aaca31",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2281,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-CELL"
        ]
      },
      "297c9864-87c6-45d9-a183-d2e97abf12fb": {
        "akc_id": "297c9864-87c6-45d9-a183-d2e97abf12fb",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-CELL"
        ]
      },
      "951a29ca-53e7-4084-83da-c594269cdb91": {
        "akc_id": "951a29ca-53e7-4084-83da-c594269cdb91",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-CELL"
        ]
      },
      "32f8a990-77e9-4c3a-81f8-45f1aba58265": {
        "akc_id": "32f8a990-77e9-4c3a-81f8-45f1aba58265",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2220,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB-CLONE"
        ]
      },
      "5835c16a-abe3-469c-b853-2d9d460cb611": {
        "akc_id": "5835c16a-abe3-469c-b853-2d9d460cb611",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB-CLONE"
        ]
      },
      "9c3883ca-107e-4992-8162-4f0cce2a816b": {
        "akc_id": "9c3883ca-107e-4992-8162-4f0cce2a816b",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB-CLONE"
        ]
      },
      "2d9cec29-d3b8-4966-ab3e-1d6581603422": {
        "akc_id": "2d9cec29-d3b8-4966-ab3e-1d6581603422",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 126,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRA"
        ]
      },
      "d5c89680-d9e9-45e7-a4b6-6078f189de63": {
        "akc_id": "d5c89680-d9e9-45e7-a4b6-6078f189de63",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRA"
        ]
      },
      "a291d9d0-d62c-4fc5-a691-9dddef434a67": {
        "akc_id": "a291d9d0-d62c-4fc5-a691-9dddef434a67",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRA"
        ]
      },
      "ba4480ed-8f86-463b-8593-dd0e4e6bfacd": {
        "akc_id": "ba4480ed-8f86-463b-8593-dd0e4e6bfacd",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 126,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB"
        ]
      },
      "dce00212-8585-4a4f-a6e0-6c27e14db075": {
        "akc_id": "dce00212-8585-4a4f-a6e0-6c27e14db075",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB"
        ]
      },
      "241f5127-169d-49bc-94f5-093f0f284d81": {
        "akc_id": "241f5127-169d-49bc-94f5-093f0f284d81",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB"
        ]
      },
      "f23f6b50-ced9-44e7-baa2-91ee90e8e0e3": {
        "akc_id": "f23f6b50-ced9-44e7-baa2-91ee90e8e0e3",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 282,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-CELL"
        ]
      },
      "45c8bbfa-caf5-4bec-af47-f36d28243519": {
        "akc_id": "45c8bbfa-caf5-4bec-af47-f36d28243519",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-CELL"
        ]
      },
      "a2e05ffb-fdca-4c83-99c6-f34890f2d5ae": {
        "akc_id": "a2e05ffb-fdca-4c83-99c6-f34890f2d5ae",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-CELL"
        ]
      },
      "f4a9d16a-7d64-4c15-b8d0-e594335006b9": {
        "akc_id": "f4a9d16a-7d64-4c15-b8d0-e594335006b9",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 126,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB-CLONE"
        ]
      },
      "778d0e39-7875-4055-8e95-8adbcd60c591": {
        "akc_id": "778d0e39-7875-4055-8e95-8adbcd60c591",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB-CLONE"
        ]
      },
      "ddfa994f-ace3-437c-b294-f80ed1236ea8": {
        "akc_id": "ddfa994f-ace3-437c-b294-f80ed1236ea8",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB-CLONE"
        ]
      },
      "68a0ab57-454e-42a6-86b0-157cac7926f1": {
        "akc_id": "68a0ab57-454e-42a6-86b0-157cac7926f1",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1115,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRA"
        ]
      },
      "9cc1b55f-43f7-48e8-82e7-ceedc8181587": {
        "akc_id": "9cc1b55f-43f7-48e8-82e7-ceedc8181587",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRA"
        ]
      },
      "f6794cf4-c978-4c0d-beb4-466ec350f4f5": {
        "akc_id": "f6794cf4-c978-4c0d-beb4-466ec350f4f5",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRA"
        ]
      },
      "aad0d53a-10b8-4b48-b184-c54ca12020f2": {
        "akc_id": "aad0d53a-10b8-4b48-b184-c54ca12020f2",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1115,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB"
        ]
      },
      "8ad34651-edaf-4b79-9b08-eb20dfab4d89": {
        "akc_id": "8ad34651-edaf-4b79-9b08-eb20dfab4d89",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB"
        ]
      },
      "f1854f99-2c4f-44c0-97e6-909af96485c3": {
        "akc_id": "f1854f99-2c4f-44c0-97e6-909af96485c3",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB"
        ]
      },
      "acdde08f-1534-4b37-a9ac-e78e991e64a7": {
        "akc_id": "acdde08f-1534-4b37-a9ac-e78e991e64a7",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1532,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-CELL"
        ]
      },
      "2c516087-13c6-4d9e-a9bc-2ad6d38bef78": {
        "akc_id": "2c516087-13c6-4d9e-a9bc-2ad6d38bef78",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-CELL"
        ]
      },
      "da6239ea-8f09-4d90-9d47-048b8fa1484c": {
        "akc_id": "da6239ea-8f09-4d90-9d47-048b8fa1484c",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-CELL"
        ]
      },
      "ff6f8009-12be-4b69-ae03-94618c96b9f1": {
        "akc_id": "ff6f8009-12be-4b69-ae03-94618c96b9f1",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1115,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB-CLONE"
        ]
      },
      "cd2f970e-1986-4a21-8cd8-c0a4ab770d5c": {
        "akc_id": "cd2f970e-1986-4a21-8cd8-c0a4ab770d5c",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB-CLONE"
        ]
      },
      "d8404bc3-3e2b-437b-af00-df846556da57": {
        "akc_id": "d8404bc3-3e2b-437b-af00-df846556da57",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB-CLONE"
        ]
      },
      "ec0e6baf-d7fc-4484-bde9-c4e443c07770": {
        "akc_id": "ec0e6baf-d7fc-4484-bde9-c4e443c07770",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3191,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRA"
        ]
      },
      "a95f89ff-fc44-4792-bc0d-6e8c86ff577a": {
        "akc_id": "a95f89ff-fc44-4792-bc0d-6e8c86ff577a",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRA"
        ]
      },
      "3a959ee6-ea16-431c-914c-7c2c39d58c36": {
        "akc_id": "3a959ee6-ea16-431c-914c-7c2c39d58c36",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRA"
        ]
      },
      "3bc5e1ce-19f6-4e1c-b247-d0838326d455": {
        "akc_id": "3bc5e1ce-19f6-4e1c-b247-d0838326d455",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3191,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB"
        ]
      },
      "ce086aab-3c31-4d51-a390-02aedfd41b68": {
        "akc_id": "ce086aab-3c31-4d51-a390-02aedfd41b68",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB"
        ]
      },
      "8efcd130-0153-4358-8095-bd2f65e2cc82": {
        "akc_id": "8efcd130-0153-4358-8095-bd2f65e2cc82",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB"
        ]
      },
      "9693fced-0815-4dc2-b858-ed31910f4209": {
        "akc_id": "9693fced-0815-4dc2-b858-ed31910f4209",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3999,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-CELL"
        ]
      },
      "4f3c53f5-03ee-49f5-9576-7853913e69eb": {
        "akc_id": "4f3c53f5-03ee-49f5-9576-7853913e69eb",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-CELL"
        ]
      },
      "4b5d03be-dc43-4a0c-b927-90fd747ff5b8": {
        "akc_id": "4b5d03be-dc43-4a0c-b927-90fd747ff5b8",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-CELL"
        ]
      },
      "e54eec21-2947-4ae8-86a8-ee70e2075e4a": {
        "akc_id": "e54eec21-2947-4ae8-86a8-ee70e2075e4a",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3191,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB-CLONE"
        ]
      },
      "032ee80b-58be-4bb7-823b-808f95cfb519": {
        "akc_id": "032ee80b-58be-4bb7-823b-808f95cfb519",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB-CLONE"
        ]
      },
      "5f9c8ac7-0acd-4a56-93d9-199237e78809": {
        "akc_id": "5f9c8ac7-0acd-4a56-93d9-199237e78809",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB-CLONE"
        ]
      },
      "1a52235c-0233-4e64-a74c-d9094d4656a0": {
        "akc_id": "1a52235c-0233-4e64-a74c-d9094d4656a0",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1065,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRA"
        ]
      },
      "2796c8f2-7e75-428a-a68c-3ec45823e886": {
        "akc_id": "2796c8f2-7e75-428a-a68c-3ec45823e886",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRA"
        ]
      },
      "94a6efdf-057c-4939-aac1-c08f66e43828": {
        "akc_id": "94a6efdf-057c-4939-aac1-c08f66e43828",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRA"
        ]
      },
      "b4813804-d264-4d70-b210-7cc779461ead": {
        "akc_id": "b4813804-d264-4d70-b210-7cc779461ead",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1065,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB"
        ]
      },
      "1bd05bfd-28db-4704-a691-19a254c65f1b": {
        "akc_id": "1bd05bfd-28db-4704-a691-19a254c65f1b",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB"
        ]
      },
      "3563bd31-05d5-48a9-88bf-2ea7dc5c6b67": {
        "akc_id": "3563bd31-05d5-48a9-88bf-2ea7dc5c6b67",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB"
        ]
      },
      "120e71fa-be13-45b8-933d-9b0d6f04d86c": {
        "akc_id": "120e71fa-be13-45b8-933d-9b0d6f04d86c",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1365,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-CELL"
        ]
      },
      "b6249874-81cc-476e-9820-9363c3c8ee84": {
        "akc_id": "b6249874-81cc-476e-9820-9363c3c8ee84",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-CELL"
        ]
      },
      "b503f223-1b94-4676-9a0a-8dcfc620c5e2": {
        "akc_id": "b503f223-1b94-4676-9a0a-8dcfc620c5e2",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-CELL"
        ]
      },
      "ed076af2-bdef-42e6-a730-5aa97d70deb7": {
        "akc_id": "ed076af2-bdef-42e6-a730-5aa97d70deb7",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1065,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB-CLONE"
        ]
      },
      "7dfbc95d-d20d-49cc-953e-ab2907ddead3": {
        "akc_id": "7dfbc95d-d20d-49cc-953e-ab2907ddead3",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB-CLONE"
        ]
      },
      "496d4e9d-b8ff-4e20-b94f-f5d7e2b34783": {
        "akc_id": "496d4e9d-b8ff-4e20-b94f-f5d7e2b34783",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB-CLONE"
        ]
      },
      "7877b911-9d49-4876-9e15-e5c7d375f22a": {
        "akc_id": "7877b911-9d49-4876-9e15-e5c7d375f22a",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4487,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRA"
        ]
      },
      "0351bb5b-6bd3-4ebf-a0f7-8830a78c37b3": {
        "akc_id": "0351bb5b-6bd3-4ebf-a0f7-8830a78c37b3",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRA"
        ]
      },
      "174f93fc-1586-49e6-b29b-c3db3666f27f": {
        "akc_id": "174f93fc-1586-49e6-b29b-c3db3666f27f",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRA"
        ]
      },
      "96aa1cca-4869-414e-ae63-574ebcd90bbb": {
        "akc_id": "96aa1cca-4869-414e-ae63-574ebcd90bbb",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4487,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB"
        ]
      },
      "c9af6ab0-8804-4edf-8f6e-1fe61e665b4f": {
        "akc_id": "c9af6ab0-8804-4edf-8f6e-1fe61e665b4f",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB"
        ]
      },
      "ab8b1af4-6cc2-413d-a929-7394dcfed584": {
        "akc_id": "ab8b1af4-6cc2-413d-a929-7394dcfed584",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB"
        ]
      },
      "17155e4f-a61d-4bc5-b39a-ad24d1966a33": {
        "akc_id": "17155e4f-a61d-4bc5-b39a-ad24d1966a33",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 6081,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-CELL"
        ]
      },
      "d6b1abed-9eaf-4864-b331-006c18db5b70": {
        "akc_id": "d6b1abed-9eaf-4864-b331-006c18db5b70",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-CELL"
        ]
      },
      "037ecfa5-3466-46de-9472-61e5dc8817eb": {
        "akc_id": "037ecfa5-3466-46de-9472-61e5dc8817eb",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-CELL"
        ]
      },
      "6f4bca70-a94b-4d27-b071-0ff9b633142f": {
        "akc_id": "6f4bca70-a94b-4d27-b071-0ff9b633142f",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4487,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB-CLONE"
        ]
      },
      "b07eec3d-4a54-4586-baf3-fa5271d1b768": {
        "akc_id": "b07eec3d-4a54-4586-baf3-fa5271d1b768",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB-CLONE"
        ]
      },
      "e613f472-8528-49da-9cc8-5fb15acc0ab4": {
        "akc_id": "e613f472-8528-49da-9cc8-5fb15acc0ab4",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB-CLONE"
        ]
      },
      "4988ef35-c9c6-4a6b-b05f-f57cac15536d": {
        "akc_id": "4988ef35-c9c6-4a6b-b05f-f57cac15536d",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3375,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRA"
        ]
      },
      "7e6628dd-dab3-4d01-b166-12d10341d727": {
        "akc_id": "7e6628dd-dab3-4d01-b166-12d10341d727",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRA"
        ]
      },
      "ee5705dd-38c0-497b-9aff-47165c24bb16": {
        "akc_id": "ee5705dd-38c0-497b-9aff-47165c24bb16",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRA"
        ]
      },
      "0b55fcdd-8654-41d4-9e80-7bb12a54f22c": {
        "akc_id": "0b55fcdd-8654-41d4-9e80-7bb12a54f22c",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3375,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB"
        ]
      },
      "c77e5a8e-3313-4c8c-8b45-6bb52a07fce5": {
        "akc_id": "c77e5a8e-3313-4c8c-8b45-6bb52a07fce5",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB"
        ]
      },
      "198ccd67-8ceb-42b3-b9a3-6cef8bbf9718": {
        "akc_id": "198ccd67-8ceb-42b3-b9a3-6cef8bbf9718",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB"
        ]
      },
      "85a0724d-c0c5-45fe-b858-133ea496f6b3": {
        "akc_id": "85a0724d-c0c5-45fe-b858-133ea496f6b3",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 5342,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-CELL"
        ]
      },
      "ff5a1b3e-d0c4-454c-b7a6-91ec24ac5a5d": {
        "akc_id": "ff5a1b3e-d0c4-454c-b7a6-91ec24ac5a5d",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-CELL"
        ]
      },
      "84acf736-b5bb-4a5e-ac52-91b80b189361": {
        "akc_id": "84acf736-b5bb-4a5e-ac52-91b80b189361",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-CELL"
        ]
      },
      "197be31f-ed28-4fd3-9fcd-d6426963017b": {
        "akc_id": "197be31f-ed28-4fd3-9fcd-d6426963017b",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3375,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB-CLONE"
        ]
      },
      "5250f26c-82bf-45a7-a43d-c4e117e54cd4": {
        "akc_id": "5250f26c-82bf-45a7-a43d-c4e117e54cd4",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB-CLONE"
        ]
      },
      "f95d5c3f-a574-475b-a76f-db6b38dbaf9c": {
        "akc_id": "f95d5c3f-a574-475b-a76f-db6b38dbaf9c",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB-CLONE"
        ]
      },
      "4c128c26-f904-4520-a472-909a7e3b9541": {
        "akc_id": "4c128c26-f904-4520-a472-909a7e3b9541",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 448,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRA"
        ]
      },
      "1124c294-e265-4579-8d3d-7420f3e2d6e2": {
        "akc_id": "1124c294-e265-4579-8d3d-7420f3e2d6e2",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRA"
        ]
      },
      "afd0ee22-d5a6-49ef-828c-1692fc3ad588": {
        "akc_id": "afd0ee22-d5a6-49ef-828c-1692fc3ad588",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRA"
        ]
      },
      "5f54b46d-3b08-406b-ab68-9e23e9b1a7af": {
        "akc_id": "5f54b46d-3b08-406b-ab68-9e23e9b1a7af",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 448,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB"
        ]
      },
      "ff57f4fc-c880-4542-96f2-f3e95e261917": {
        "akc_id": "ff57f4fc-c880-4542-96f2-f3e95e261917",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB"
        ]
      },
      "3824aa67-8dd2-4292-ba52-423df1bfb271": {
        "akc_id": "3824aa67-8dd2-4292-ba52-423df1bfb271",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB"
        ]
      },
      "81c9547a-b666-4a45-b87f-395e2a880c2f": {
        "akc_id": "81c9547a-b666-4a45-b87f-395e2a880c2f",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 549,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-CELL"
        ]
      },
      "c396d785-dd5a-4a62-a877-9b3d838ce5f6": {
        "akc_id": "c396d785-dd5a-4a62-a877-9b3d838ce5f6",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-CELL"
        ]
      },
      "bb66db4b-62dd-4e07-8319-a5079dd2ebe0": {
        "akc_id": "bb66db4b-62dd-4e07-8319-a5079dd2ebe0",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-CELL"
        ]
      },
      "b58b0fe6-795e-47d5-9452-8a0c753a7234": {
        "akc_id": "b58b0fe6-795e-47d5-9452-8a0c753a7234",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 448,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB-CLONE"
        ]
      },
      "bb79b3c6-6231-4ff3-90e9-be9ef7caecd4": {
        "akc_id": "bb79b3c6-6231-4ff3-90e9-be9ef7caecd4",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB-CLONE"
        ]
      },
      "362e634c-994d-4dcb-8374-7ed758f29be3": {
        "akc_id": "362e634c-994d-4dcb-8374-7ed758f29be3",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB-CLONE"
        ]
      },
      "2dc49025-a319-4674-b2c6-5623a2ac8446": {
        "akc_id": "2dc49025-a319-4674-b2c6-5623a2ac8446",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 11425,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRA"
        ]
      },
      "f1c41085-3b53-4381-9246-90847ebeb621": {
        "akc_id": "f1c41085-3b53-4381-9246-90847ebeb621",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRA"
        ]
      },
      "a509381c-0786-4261-8300-f0c0c5a55ec2": {
        "akc_id": "a509381c-0786-4261-8300-f0c0c5a55ec2",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRA"
        ]
      },
      "ddbb6e51-fe62-4f69-a47e-7d070e4d7ad1": {
        "akc_id": "ddbb6e51-fe62-4f69-a47e-7d070e4d7ad1",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 11425,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB"
        ]
      },
      "71df90e7-93c7-4838-88aa-23192d416adb": {
        "akc_id": "71df90e7-93c7-4838-88aa-23192d416adb",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB"
        ]
      },
      "d73dd642-7177-4607-b2bc-f661cd1ee66d": {
        "akc_id": "d73dd642-7177-4607-b2bc-f661cd1ee66d",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB"
        ]
      },
      "88ad4abc-404b-4350-9eb1-9877a4fa7e5b": {
        "akc_id": "88ad4abc-404b-4350-9eb1-9877a4fa7e5b",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 11118,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-CELL"
        ]
      },
      "23b053da-e309-4e0c-b74e-4266e463ab3e": {
        "akc_id": "23b053da-e309-4e0c-b74e-4266e463ab3e",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-CELL"
        ]
      },
      "95fd7dcc-ab85-4bab-a0c8-b139372cc726": {
        "akc_id": "95fd7dcc-ab85-4bab-a0c8-b139372cc726",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-CELL"
        ]
      },
      "1f05ad8d-e301-4908-bcac-5931d3ac1fc5": {
        "akc_id": "1f05ad8d-e301-4908-bcac-5931d3ac1fc5",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 11425,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB-CLONE"
        ]
      },
      "0fc35630-81f7-425a-9e78-64d7bb777280": {
        "akc_id": "0fc35630-81f7-425a-9e78-64d7bb777280",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB-CLONE"
        ]
      },
      "5468595f-2342-4723-868c-5a08bf05bb98": {
        "akc_id": "5468595f-2342-4723-868c-5a08bf05bb98",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB-CLONE"
        ]
      },
      "f9007ba1-20a1-41ca-b2a3-2f3c3789589d": {
        "akc_id": "f9007ba1-20a1-41ca-b2a3-2f3c3789589d",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+CD8+CD39+",
        "single_cell": true,
        "cell_number": 5469,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRA"
        ]
      },
      "ba9c3231-c050-4cb8-bdc7-f0622c3680cc": {
        "akc_id": "ba9c3231-c050-4cb8-bdc7-f0622c3680cc",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRA"
        ]
      },
      "bb379de1-9e5c-42b6-99c3-78000f4d81cb": {
        "akc_id": "bb379de1-9e5c-42b6-99c3-78000f4d81cb",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRA"
        ]
      },
      "282e8fe6-29d9-41af-832a-fb70e3d23b2e": {
        "akc_id": "282e8fe6-29d9-41af-832a-fb70e3d23b2e",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+CD8+CD39+",
        "single_cell": true,
        "cell_number": 5469,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB"
        ]
      },
      "23e0aa3e-0c6f-4c74-a096-5b8d3df2a4e3": {
        "akc_id": "23e0aa3e-0c6f-4c74-a096-5b8d3df2a4e3",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB"
        ]
      },
      "9a3da690-4508-4558-8b48-629b34e268a4": {
        "akc_id": "9a3da690-4508-4558-8b48-629b34e268a4",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB"
        ]
      },
      "8f8430a6-a353-4bd9-93e7-e0a0a91fafee": {
        "akc_id": "8f8430a6-a353-4bd9-93e7-e0a0a91fafee",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+CD8+CD39+",
        "single_cell": true,
        "cell_number": 5392,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-CELL"
        ]
      },
      "6a168251-6c32-4934-8511-74efe3bb85ac": {
        "akc_id": "6a168251-6c32-4934-8511-74efe3bb85ac",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-CELL"
        ]
      },
      "89f43587-f0d4-4bb9-8c1a-ab9d36de358d": {
        "akc_id": "89f43587-f0d4-4bb9-8c1a-ab9d36de358d",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-CELL"
        ]
      },
      "b1f6bfb7-e264-49cf-a912-2f4fbde826ff": {
        "akc_id": "b1f6bfb7-e264-49cf-a912-2f4fbde826ff",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+CD8+CD39+",
        "single_cell": true,
        "cell_number": 5469,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB-CLONE"
        ]
      },
      "b27f0eae-cf09-4983-972c-889822e355eb": {
        "akc_id": "b27f0eae-cf09-4983-972c-889822e355eb",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB-CLONE"
        ]
      },
      "edf472bf-ca13-46ce-a5b2-1c9b8ff5add6": {
        "akc_id": "edf472bf-ca13-46ce-a5b2-1c9b8ff5add6",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB-CLONE"
        ]
      },
      "6b688ab0-f151-401e-a957-b2019ba41cd0": {
        "akc_id": "6b688ab0-f151-401e-a957-b2019ba41cd0",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 84,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRA"
        ]
      },
      "47b8d0e9-7710-4d28-95ec-b3d65eab2bb8": {
        "akc_id": "47b8d0e9-7710-4d28-95ec-b3d65eab2bb8",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRA"
        ]
      },
      "479483c4-fee4-4a34-ad3f-64082daad6aa": {
        "akc_id": "479483c4-fee4-4a34-ad3f-64082daad6aa",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRA"
        ]
      },
      "037abfe2-1933-4fcc-97e7-d679039e87f0": {
        "akc_id": "037abfe2-1933-4fcc-97e7-d679039e87f0",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 84,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB"
        ]
      },
      "9f8854d6-5d18-4d66-a316-4cbba46dbba3": {
        "akc_id": "9f8854d6-5d18-4d66-a316-4cbba46dbba3",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB"
        ]
      },
      "6e623efb-a2e8-48dd-b1d1-bc35d24085f9": {
        "akc_id": "6e623efb-a2e8-48dd-b1d1-bc35d24085f9",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB"
        ]
      },
      "7702fd81-1d42-4d89-82bd-43b98394a98b": {
        "akc_id": "7702fd81-1d42-4d89-82bd-43b98394a98b",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 136,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-CELL"
        ]
      },
      "49da878b-ed3d-4f12-a153-29a404a1b576": {
        "akc_id": "49da878b-ed3d-4f12-a153-29a404a1b576",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-CELL"
        ]
      },
      "56e16ca4-9f46-455e-96b0-c7dc6369de46": {
        "akc_id": "56e16ca4-9f46-455e-96b0-c7dc6369de46",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-CELL"
        ]
      },
      "fa1d74cb-3076-44f1-9999-1db3d4caa62e": {
        "akc_id": "fa1d74cb-3076-44f1-9999-1db3d4caa62e",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 84,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB-CLONE"
        ]
      },
      "acd4c043-f7da-4639-a3a5-5b242a4cfc9a": {
        "akc_id": "acd4c043-f7da-4639-a3a5-5b242a4cfc9a",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB-CLONE"
        ]
      },
      "c099b911-b114-476a-bac6-7b43318be212": {
        "akc_id": "c099b911-b114-476a-bac6-7b43318be212",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB-CLONE"
        ]
      },
      "003c781f-8f48-43cf-bdf7-a926886a1d3a": {
        "akc_id": "003c781f-8f48-43cf-bdf7-a926886a1d3a",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1570,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRA"
        ]
      },
      "23d8c16f-fb22-4f32-a92d-f38a41d0544d": {
        "akc_id": "23d8c16f-fb22-4f32-a92d-f38a41d0544d",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRA"
        ]
      },
      "00227008-b21f-4eb9-ac00-66a543e91a22": {
        "akc_id": "00227008-b21f-4eb9-ac00-66a543e91a22",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRA"
        ]
      },
      "e6ff0388-8291-4d08-abc0-6e1639188d0a": {
        "akc_id": "e6ff0388-8291-4d08-abc0-6e1639188d0a",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1570,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB"
        ]
      },
      "0ab1ae94-147c-41a6-a824-96fb05c10a36": {
        "akc_id": "0ab1ae94-147c-41a6-a824-96fb05c10a36",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB"
        ]
      },
      "93110946-4995-4a07-bb77-17e47b0b4472": {
        "akc_id": "93110946-4995-4a07-bb77-17e47b0b4472",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB"
        ]
      },
      "6a7f9ca7-f5b4-4b13-ad63-50b24cbe9428": {
        "akc_id": "6a7f9ca7-f5b4-4b13-ad63-50b24cbe9428",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3149,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-CELL"
        ]
      },
      "b34e067a-6993-4e42-a410-ee57e1edf61f": {
        "akc_id": "b34e067a-6993-4e42-a410-ee57e1edf61f",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-CELL"
        ]
      },
      "656fba6a-8a4e-4a68-be0e-5799b8ff15f5": {
        "akc_id": "656fba6a-8a4e-4a68-be0e-5799b8ff15f5",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-CELL"
        ]
      },
      "496685e8-0812-431d-8240-a98faa4acc9a": {
        "akc_id": "496685e8-0812-431d-8240-a98faa4acc9a",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1570,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE"
        ]
      },
      "aa1fb87b-5b6b-447f-8294-272c6d3a8cd7": {
        "akc_id": "aa1fb87b-5b6b-447f-8294-272c6d3a8cd7",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE"
        ]
      },
      "e01e42b6-0861-4033-89ec-da3fcd2ae95b": {
        "akc_id": "e01e42b6-0861-4033-89ec-da3fcd2ae95b",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE"
        ]
      },
      "f5baae73-66e1-46c0-b7a6-3d73583d9f75": {
        "akc_id": "f5baae73-66e1-46c0-b7a6-3d73583d9f75",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1384,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRA"
        ]
      },
      "ed5f6a76-3e1d-4de0-8f31-591c9389d64d": {
        "akc_id": "ed5f6a76-3e1d-4de0-8f31-591c9389d64d",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRA"
        ]
      },
      "3e51f305-6dc6-4d96-8ec1-1ecc4c589e16": {
        "akc_id": "3e51f305-6dc6-4d96-8ec1-1ecc4c589e16",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRA"
        ]
      },
      "135eb216-e8c8-4f87-937a-04878195ab3a": {
        "akc_id": "135eb216-e8c8-4f87-937a-04878195ab3a",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1384,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB"
        ]
      },
      "256b954f-0b38-4fc9-a6ab-3ad08b527414": {
        "akc_id": "256b954f-0b38-4fc9-a6ab-3ad08b527414",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB"
        ]
      },
      "0c03ad34-af7a-457c-9b57-62721e432149": {
        "akc_id": "0c03ad34-af7a-457c-9b57-62721e432149",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB"
        ]
      },
      "098e32ea-e469-40b4-8c7c-ac11992cbfcb": {
        "akc_id": "098e32ea-e469-40b4-8c7c-ac11992cbfcb",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2761,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-CELL"
        ]
      },
      "be05af51-5738-42fb-9cfc-8f69fa06aaf7": {
        "akc_id": "be05af51-5738-42fb-9cfc-8f69fa06aaf7",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-CELL"
        ]
      },
      "55818de7-c8c9-40a7-946b-84006812e981": {
        "akc_id": "55818de7-c8c9-40a7-946b-84006812e981",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-CELL"
        ]
      },
      "c902303b-2219-4cad-a97c-93936ab471a6": {
        "akc_id": "c902303b-2219-4cad-a97c-93936ab471a6",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1384,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE"
        ]
      },
      "80a5acc4-62d3-42cc-9280-1d9155ab4578": {
        "akc_id": "80a5acc4-62d3-42cc-9280-1d9155ab4578",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE"
        ]
      },
      "a342eed9-fc26-40ec-80ac-7384ed827b4d": {
        "akc_id": "a342eed9-fc26-40ec-80ac-7384ed827b4d",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE"
        ]
      },
      "29c6a3c2-f2f0-42ae-89b4-11ba10263a80": {
        "akc_id": "29c6a3c2-f2f0-42ae-89b4-11ba10263a80",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4618,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRA"
        ]
      },
      "286c4953-454b-447d-86b7-5208b16bcde5": {
        "akc_id": "286c4953-454b-447d-86b7-5208b16bcde5",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRA"
        ]
      },
      "07a40141-fdb4-4803-b862-dd61550a21c6": {
        "akc_id": "07a40141-fdb4-4803-b862-dd61550a21c6",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRA"
        ]
      },
      "db14b6d1-f34d-4f35-814b-d5569cb55b6c": {
        "akc_id": "db14b6d1-f34d-4f35-814b-d5569cb55b6c",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4618,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB"
        ]
      },
      "a4992a12-27f2-4e57-8677-c35b9fe228c3": {
        "akc_id": "a4992a12-27f2-4e57-8677-c35b9fe228c3",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB"
        ]
      },
      "c3521599-ce88-4241-a252-85db9d243445": {
        "akc_id": "c3521599-ce88-4241-a252-85db9d243445",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB"
        ]
      },
      "71c0463b-f617-4392-bdcd-3ed9f70b75d3": {
        "akc_id": "71c0463b-f617-4392-bdcd-3ed9f70b75d3",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 6564,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-CELL"
        ]
      },
      "f8b0e496-93f0-4627-8273-f47446c8de86": {
        "akc_id": "f8b0e496-93f0-4627-8273-f47446c8de86",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-CELL"
        ]
      },
      "713e8140-0846-4ada-834e-7e39d3e19749": {
        "akc_id": "713e8140-0846-4ada-834e-7e39d3e19749",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-CELL"
        ]
      },
      "fd4d38f9-f4c7-43f9-861c-82da298d00d2": {
        "akc_id": "fd4d38f9-f4c7-43f9-861c-82da298d00d2",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4618,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB-CLONE"
        ]
      },
      "521b1c9a-eea8-427b-8d36-4105003b3ce8": {
        "akc_id": "521b1c9a-eea8-427b-8d36-4105003b3ce8",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB-CLONE"
        ]
      },
      "b28ec114-d4fe-4a73-941c-a03efbb708cf": {
        "akc_id": "b28ec114-d4fe-4a73-941c-a03efbb708cf",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB-CLONE"
        ]
      },
      "b450dce8-1317-4cf9-8770-9929565afba4": {
        "akc_id": "b450dce8-1317-4cf9-8770-9929565afba4",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1047,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRA"
        ]
      },
      "ac8c36df-fb95-475d-82a8-b7acb42c67da": {
        "akc_id": "ac8c36df-fb95-475d-82a8-b7acb42c67da",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRA"
        ]
      },
      "2c82f852-2a7f-4405-a544-788f9271e3a1": {
        "akc_id": "2c82f852-2a7f-4405-a544-788f9271e3a1",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRA"
        ]
      },
      "74eb6abf-1e46-421c-a929-07a265d87574": {
        "akc_id": "74eb6abf-1e46-421c-a929-07a265d87574",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1047,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB"
        ]
      },
      "79de63e8-b21e-4dce-b3f2-74583248eebc": {
        "akc_id": "79de63e8-b21e-4dce-b3f2-74583248eebc",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB"
        ]
      },
      "e61d68e3-d84b-4a38-a2df-deac7c811b96": {
        "akc_id": "e61d68e3-d84b-4a38-a2df-deac7c811b96",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB"
        ]
      },
      "5fe24a76-ad38-416a-8efa-917cd9a52427": {
        "akc_id": "5fe24a76-ad38-416a-8efa-917cd9a52427",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1768,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-CELL"
        ]
      },
      "5935bf69-5aeb-4774-8e67-11b455150006": {
        "akc_id": "5935bf69-5aeb-4774-8e67-11b455150006",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-CELL"
        ]
      },
      "0f6218e0-b1d0-4a2e-9c69-3a451bb2a595": {
        "akc_id": "0f6218e0-b1d0-4a2e-9c69-3a451bb2a595",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-CELL"
        ]
      },
      "a3cd669d-6c61-493c-b9a7-6fae7c6df059": {
        "akc_id": "a3cd669d-6c61-493c-b9a7-6fae7c6df059",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1047,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB-CLONE"
        ]
      },
      "8cf7940d-3dfe-4115-867e-28c3a4bfd7a3": {
        "akc_id": "8cf7940d-3dfe-4115-867e-28c3a4bfd7a3",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB-CLONE"
        ]
      },
      "0f422f80-06db-401d-8c1d-6de56cf7fb86": {
        "akc_id": "0f422f80-06db-401d-8c1d-6de56cf7fb86",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB-CLONE"
        ]
      },
      "7c30dc56-fca4-4dc1-afa9-eb18bee0127b": {
        "akc_id": "7c30dc56-fca4-4dc1-afa9-eb18bee0127b",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1840,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRA"
        ]
      },
      "a43c4c45-5327-4dc3-8e95-fcf57092e9fd": {
        "akc_id": "a43c4c45-5327-4dc3-8e95-fcf57092e9fd",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRA"
        ]
      },
      "3188bca3-b4d6-4f15-910f-a49349abbc55": {
        "akc_id": "3188bca3-b4d6-4f15-910f-a49349abbc55",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRA"
        ]
      },
      "5cf1bfca-6778-4d1e-a024-a7c3a225abac": {
        "akc_id": "5cf1bfca-6778-4d1e-a024-a7c3a225abac",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1840,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB"
        ]
      },
      "2c8f778f-7857-4f83-abb9-fff8c8d13163": {
        "akc_id": "2c8f778f-7857-4f83-abb9-fff8c8d13163",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB"
        ]
      },
      "f91634d9-5ad4-42fb-8a6e-336665af806e": {
        "akc_id": "f91634d9-5ad4-42fb-8a6e-336665af806e",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB"
        ]
      },
      "af5d960f-2176-4f92-adc7-4d7909c7a27b": {
        "akc_id": "af5d960f-2176-4f92-adc7-4d7909c7a27b",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2883,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-CELL"
        ]
      },
      "1ceeda9b-03eb-40a0-98d5-a40111ce087e": {
        "akc_id": "1ceeda9b-03eb-40a0-98d5-a40111ce087e",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-CELL"
        ]
      },
      "e5e78659-6bc5-4a67-a1e4-14db44d0c4a1": {
        "akc_id": "e5e78659-6bc5-4a67-a1e4-14db44d0c4a1",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-CELL"
        ]
      },
      "5fc0913c-3eaf-4c15-a241-c04a4871e704": {
        "akc_id": "5fc0913c-3eaf-4c15-a241-c04a4871e704",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 1840,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB-CLONE"
        ]
      },
      "c8683d2f-19d3-46e4-b72a-7ca4ee138ac7": {
        "akc_id": "c8683d2f-19d3-46e4-b72a-7ca4ee138ac7",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB-CLONE"
        ]
      },
      "f9f6314c-ba93-4ecb-8001-9af3461d4684": {
        "akc_id": "f9f6314c-ba93-4ecb-8001-9af3461d4684",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB-CLONE"
        ]
      },
      "a3aa7861-18ed-4ea3-810c-9d0278d88b8d": {
        "akc_id": "a3aa7861-18ed-4ea3-810c-9d0278d88b8d",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 639,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRA"
        ]
      },
      "d27bb73c-1dc8-4207-873e-1fc1f790e579": {
        "akc_id": "d27bb73c-1dc8-4207-873e-1fc1f790e579",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRA"
        ]
      },
      "6ed718f9-ff93-4c8d-86cc-ed37ff1f2167": {
        "akc_id": "6ed718f9-ff93-4c8d-86cc-ed37ff1f2167",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRA"
        ]
      },
      "53f6e804-fb4f-4f4b-8084-348648a22c3f": {
        "akc_id": "53f6e804-fb4f-4f4b-8084-348648a22c3f",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 639,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB"
        ]
      },
      "5647fbdd-c6dd-4d2e-bebe-f7c2fb7503f6": {
        "akc_id": "5647fbdd-c6dd-4d2e-bebe-f7c2fb7503f6",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB"
        ]
      },
      "1b3d1dd2-cc81-46f4-ab1a-4734046ab5dd": {
        "akc_id": "1b3d1dd2-cc81-46f4-ab1a-4734046ab5dd",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB"
        ]
      },
      "79cc743b-a34e-4049-b592-f8d1d91b18ab": {
        "akc_id": "79cc743b-a34e-4049-b592-f8d1d91b18ab",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 809,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-CELL"
        ]
      },
      "550becc8-27eb-479b-b9d0-1cd7c278f590": {
        "akc_id": "550becc8-27eb-479b-b9d0-1cd7c278f590",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-CELL"
        ]
      },
      "6517a6c5-fcb0-49c1-aad6-03470eca3e70": {
        "akc_id": "6517a6c5-fcb0-49c1-aad6-03470eca3e70",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-CELL"
        ]
      },
      "7f56d22c-0b9d-4cda-b17a-760864300947": {
        "akc_id": "7f56d22c-0b9d-4cda-b17a-760864300947",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 639,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB-CLONE"
        ]
      },
      "e8d5ab25-61e3-492b-861d-f716060d7f92": {
        "akc_id": "e8d5ab25-61e3-492b-861d-f716060d7f92",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB-CLONE"
        ]
      },
      "33bf58ec-6865-4a9b-9448-6c5f28985399": {
        "akc_id": "33bf58ec-6865-4a9b-9448-6c5f28985399",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB-CLONE"
        ]
      },
      "1034108d-f0ae-445e-a888-afbd1f0d6906": {
        "akc_id": "1034108d-f0ae-445e-a888-afbd1f0d6906",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2327,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRA"
        ]
      },
      "396b09b3-49ce-4aad-8c74-973c9a27b1d9": {
        "akc_id": "396b09b3-49ce-4aad-8c74-973c9a27b1d9",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRA"
        ]
      },
      "38156899-be6e-495d-a918-3ebdf93a5df6": {
        "akc_id": "38156899-be6e-495d-a918-3ebdf93a5df6",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRA"
        ]
      },
      "a9df473b-487e-47fe-8c3e-5bb2a5f1b12f": {
        "akc_id": "a9df473b-487e-47fe-8c3e-5bb2a5f1b12f",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2327,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB"
        ]
      },
      "a56c156e-8685-4261-b838-f68320c450c9": {
        "akc_id": "a56c156e-8685-4261-b838-f68320c450c9",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB"
        ]
      },
      "d42c6dce-7ebd-46af-830e-6ee9d990a278": {
        "akc_id": "d42c6dce-7ebd-46af-830e-6ee9d990a278",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB"
        ]
      },
      "d2df673f-5c1f-456b-996b-db9b362e5d06": {
        "akc_id": "d2df673f-5c1f-456b-996b-db9b362e5d06",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2688,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-CELL"
        ]
      },
      "7a8e2a9e-32cd-4fcb-b3df-8833c8212aa3": {
        "akc_id": "7a8e2a9e-32cd-4fcb-b3df-8833c8212aa3",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-CELL"
        ]
      },
      "d95e3d2b-202a-42a4-8aac-e4e97732a4e1": {
        "akc_id": "d95e3d2b-202a-42a4-8aac-e4e97732a4e1",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-CELL"
        ]
      },
      "ef24c86d-a938-4ddb-9c06-b85e1ba40d03": {
        "akc_id": "ef24c86d-a938-4ddb-9c06-b85e1ba40d03",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2327,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB-CLONE"
        ]
      },
      "65f69726-f045-4b1c-93fb-98b845425856": {
        "akc_id": "65f69726-f045-4b1c-93fb-98b845425856",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB-CLONE"
        ]
      },
      "9321985f-02bc-4900-b02f-ed5589019faa": {
        "akc_id": "9321985f-02bc-4900-b02f-ed5589019faa",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB-CLONE"
        ]
      },
      "7718e289-a379-4862-b695-ffdeee3bcc85": {
        "akc_id": "7718e289-a379-4862-b695-ffdeee3bcc85",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 57,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRA"
        ]
      },
      "b0957bc2-d69d-4a2f-b0d9-d5016c4a6982": {
        "akc_id": "b0957bc2-d69d-4a2f-b0d9-d5016c4a6982",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRA"
        ]
      },
      "8c0194a4-14a3-4a8a-a053-9d5b400b7f46": {
        "akc_id": "8c0194a4-14a3-4a8a-a053-9d5b400b7f46",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRA"
        ]
      },
      "bbe45efe-4e5a-4a28-87ac-84d896484605": {
        "akc_id": "bbe45efe-4e5a-4a28-87ac-84d896484605",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 57,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB"
        ]
      },
      "cc115839-2d40-4243-a830-9b33f89f3c5d": {
        "akc_id": "cc115839-2d40-4243-a830-9b33f89f3c5d",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB"
        ]
      },
      "010678ea-dff9-453e-a3a3-7b9b0138d1f4": {
        "akc_id": "010678ea-dff9-453e-a3a3-7b9b0138d1f4",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB"
        ]
      },
      "e82da13d-f6b9-4a21-a67a-48e932f993b4": {
        "akc_id": "e82da13d-f6b9-4a21-a67a-48e932f993b4",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 96,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-CELL"
        ]
      },
      "c35cf9c6-6a3c-4bc3-8544-b6b63677f465": {
        "akc_id": "c35cf9c6-6a3c-4bc3-8544-b6b63677f465",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-CELL"
        ]
      },
      "754ff2af-29be-4d6d-8cf9-af723e1f27be": {
        "akc_id": "754ff2af-29be-4d6d-8cf9-af723e1f27be",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-CELL"
        ]
      },
      "212d34be-d459-4b8e-9b79-fd7270b24c26": {
        "akc_id": "212d34be-d459-4b8e-9b79-fd7270b24c26",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 57,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB-CLONE"
        ]
      },
      "b24b6219-204b-40ad-9898-527ee825cf2f": {
        "akc_id": "b24b6219-204b-40ad-9898-527ee825cf2f",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB-CLONE"
        ]
      },
      "cc3ba08f-0e3d-4204-9017-726889b09982": {
        "akc_id": "cc3ba08f-0e3d-4204-9017-726889b09982",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB-CLONE"
        ]
      },
      "a35f17f7-74c8-4833-a26d-95b8115ba675": {
        "akc_id": "a35f17f7-74c8-4833-a26d-95b8115ba675",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4483,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRA"
        ]
      },
      "d9058baf-b9bc-45e5-80b4-bb6e3740d8be": {
        "akc_id": "d9058baf-b9bc-45e5-80b4-bb6e3740d8be",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRA"
        ]
      },
      "d8dee84d-4e78-4cde-b71d-2bc9af17a4c1": {
        "akc_id": "d8dee84d-4e78-4cde-b71d-2bc9af17a4c1",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRA"
        ]
      },
      "c2c66a85-7aec-4424-9aa9-6cf023e5b114": {
        "akc_id": "c2c66a85-7aec-4424-9aa9-6cf023e5b114",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4483,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB"
        ]
      },
      "09734f5a-06fe-41e7-85b2-5029489e3979": {
        "akc_id": "09734f5a-06fe-41e7-85b2-5029489e3979",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB"
        ]
      },
      "f81d8a91-9787-4842-8402-d7043bf5b2a4": {
        "akc_id": "f81d8a91-9787-4842-8402-d7043bf5b2a4",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB"
        ]
      },
      "204b12d5-1a63-4480-aefb-a28a02606c69": {
        "akc_id": "204b12d5-1a63-4480-aefb-a28a02606c69",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 5268,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-CELL"
        ]
      },
      "35ed5d13-70f5-44ac-bbf4-a15078e0fbcc": {
        "akc_id": "35ed5d13-70f5-44ac-bbf4-a15078e0fbcc",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-CELL"
        ]
      },
      "bc395958-1b78-4a69-825f-be7be8f60df9": {
        "akc_id": "bc395958-1b78-4a69-825f-be7be8f60df9",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-CELL"
        ]
      },
      "52913150-4861-49c3-8317-c12f140e53b3": {
        "akc_id": "52913150-4861-49c3-8317-c12f140e53b3",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 4483,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB-CLONE"
        ]
      },
      "1cb80c9c-fc9a-42f7-83bd-17f7ac7a39e2": {
        "akc_id": "1cb80c9c-fc9a-42f7-83bd-17f7ac7a39e2",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB-CLONE"
        ]
      },
      "82b1e311-2e8f-45ff-9cbb-1b3eebb93771": {
        "akc_id": "82b1e311-2e8f-45ff-9cbb-1b3eebb93771",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB-CLONE"
        ]
      },
      "86204ed3-2ca2-4c33-9c0a-4f838f76158a": {
        "akc_id": "86204ed3-2ca2-4c33-9c0a-4f838f76158a",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 556,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRA"
        ]
      },
      "45c8e9b4-a8e0-4dd6-8e6b-6fcac3f0a75d": {
        "akc_id": "45c8e9b4-a8e0-4dd6-8e6b-6fcac3f0a75d",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRA"
        ]
      },
      "7bfafe19-ad74-460a-9c8f-f8af1128f8cf": {
        "akc_id": "7bfafe19-ad74-460a-9c8f-f8af1128f8cf",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRA"
        ]
      },
      "e04c91fb-8785-444c-a135-08e2e57bc2ae": {
        "akc_id": "e04c91fb-8785-444c-a135-08e2e57bc2ae",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 556,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB"
        ]
      },
      "0687f6ff-df2a-4484-a923-183d9e78467e": {
        "akc_id": "0687f6ff-df2a-4484-a923-183d9e78467e",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB"
        ]
      },
      "aae9edc2-aa6d-45da-b9aa-fe539f6291e3": {
        "akc_id": "aae9edc2-aa6d-45da-b9aa-fe539f6291e3",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB"
        ]
      },
      "d1a4ea59-c0fd-4a85-9285-106e132d898e": {
        "akc_id": "d1a4ea59-c0fd-4a85-9285-106e132d898e",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 790,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-CELL"
        ]
      },
      "76e3c414-fbaf-4302-bd2b-6df65094ada1": {
        "akc_id": "76e3c414-fbaf-4302-bd2b-6df65094ada1",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-CELL"
        ]
      },
      "67769e17-59b0-4b67-a821-cd32d1387625": {
        "akc_id": "67769e17-59b0-4b67-a821-cd32d1387625",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-CELL"
        ]
      },
      "1eea5757-a575-4d56-8ba4-458fd46dfe07": {
        "akc_id": "1eea5757-a575-4d56-8ba4-458fd46dfe07",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 556,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB-CLONE"
        ]
      },
      "70c9cb49-1573-4002-9585-a32f7254ce54": {
        "akc_id": "70c9cb49-1573-4002-9585-a32f7254ce54",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB-CLONE"
        ]
      },
      "974c45f2-1ad8-4039-9324-7833b1c08e38": {
        "akc_id": "974c45f2-1ad8-4039-9324-7833b1c08e38",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB-CLONE"
        ]
      },
      "22b0cbfa-f74c-4c38-b2b1-af42f02c37df": {
        "akc_id": "22b0cbfa-f74c-4c38-b2b1-af42f02c37df",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2608,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRA"
        ]
      },
      "56c61c92-7549-4076-8749-e76863c75a41": {
        "akc_id": "56c61c92-7549-4076-8749-e76863c75a41",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRA"
        ]
      },
      "61a8db8b-f89c-4cc9-9d69-adf9e8360fa3": {
        "akc_id": "61a8db8b-f89c-4cc9-9d69-adf9e8360fa3",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRA"
        ]
      },
      "5296ef2a-abfa-4e75-833c-3985097667a5": {
        "akc_id": "5296ef2a-abfa-4e75-833c-3985097667a5",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2608,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB"
        ]
      },
      "e6cf58d6-0803-4b90-be35-cd2e5477188a": {
        "akc_id": "e6cf58d6-0803-4b90-be35-cd2e5477188a",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB"
        ]
      },
      "03e59b13-e9bc-4903-8916-b9606ba99312": {
        "akc_id": "03e59b13-e9bc-4903-8916-b9606ba99312",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB"
        ]
      },
      "abb1674e-5a8b-4c2a-983e-418b96a094cb": {
        "akc_id": "abb1674e-5a8b-4c2a-983e-418b96a094cb",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 3049,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-CELL"
        ]
      },
      "fb0aef34-1ce0-426b-9f62-b249dc337eab": {
        "akc_id": "fb0aef34-1ce0-426b-9f62-b249dc337eab",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-CELL"
        ]
      },
      "e52b3f1b-ec5e-4ca9-ba76-5ec8759eff60": {
        "akc_id": "e52b3f1b-ec5e-4ca9-ba76-5ec8759eff60",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-CELL"
        ]
      },
      "830a362b-712a-420d-b461-12c417eda2d0": {
        "akc_id": "830a362b-712a-420d-b461-12c417eda2d0",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "cell_subset": {
          "label": "T cell",
          "id": "CL:0000084"
        },
        "cell_phenotype": "CD45+CD3+",
        "single_cell": true,
        "cell_number": 2608,
        "cells_per_reaction": 1,
        "cell_storage": true,
        "cell_quality": "Propidium iodine (P3566, Invitrogen) was used for live/dead staining at a final concentration of 2.5 g/ml",
        "cell_isolation": "Cells were categorized as peri-tumoral T cells (CD45+CD3+), other peri-tumoral lymphocytes (CD45+CD3) and malignant/stromal cells (CD45CD3). For patients su009, su010, su011, su012, su013 and su014, only peri-tumoral T cells were isolated and used for scRNA-seq. For sample su010-S, we additionally isolated CD8+CD39+ peri-tumoral T cells (CD45+CD3+CD8+CD39+).",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB-CLONE"
        ]
      },
      "4527fa0e-ef6b-406c-8687-4592dec3577c": {
        "akc_id": "4527fa0e-ef6b-406c-8687-4592dec3577c",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "template_class": "RNA",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB-CLONE"
        ]
      },
      "f02f3761-e74d-47ed-8b47-a1b6e630acd3": {
        "akc_id": "f02f3761-e74d-47ed-8b47-a1b6e630acd3",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "library_generation_method": "RT(oligo-dT)+TS(UMI)+PCR",
        "library_generation_protocol": "The scRNA-seq and scTCR-seq libraries were prepared using the 10x Single Cell Immune Profiling Solution Kit, according to the manufacturers instructions. In brief, FACS-sorted cells were washed once with PBS containing 0.04% bovine serum albumin (BSA) and resuspended in PBS containing 0.04% BSA to a final concentration of 100800 cells per l as determined by hemacytometer. Cells were captured in droplets at a targeted cell recovery of 5007,000 cells, resulting in estimated multiplet rates of 0.45.4%. Following reverse transcription and cell barcoding in droplets, emulsions were broken and cDNA purified using Dynabeads MyOne SILANE followed by PCR amplification (98 C for 45 s; 1318 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Amplified cDNA was then used for both 5 gene expression library construction and TCR enrichment. For gene expression library construction, 2.450 ng of amplified cDNA was fragmented and end-repaired, double-sided size-selected with SPRIselect beads, PCR-amplified with sample indexing primers (98 C for 45 s; 1416 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and double-sided size-selected with SPRIselect beads. For TCR library construction, TCR transcripts were enriched from 2 l of amplified cDNA by PCR (primer sets 1 and 2: 98 C for 45 s; 10 cycles of 98 C for 20 s, 67 C for 30 s, 72 C for 1 min; 72 C for 1 min). Following TCR enrichment, 550 ng of enriched PCR product was fragmented and end-repaired, size-selected with SPRIselect beads, PCR-amplified with sample-indexing primers (98 C for 45 s; 9 cycles of 98 C for 20 s, 54 C for 30 s, 72 C for 20 s; 72 C for 1 min), and sizeselected with SPRIselect beads.",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB-CLONE"
        ]
      }
    },
    "assays": {
      "a3a278d9-5fe0-40c6-ae2d-362af62c6056": {
        "akc_id": "a3a278d9-5fe0-40c6-ae2d-362af62c6056",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRA"
        ]
      },
      "baf7043e-df2c-4ae1-b011-493c73de3a09": {
        "akc_id": "baf7043e-df2c-4ae1-b011-493c73de3a09",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB"
        ]
      },
      "8745a4fa-6955-4c84-8c53-c10f9b48b5e8": {
        "akc_id": "8745a4fa-6955-4c84-8c53-c10f9b48b5e8",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-CELL"
        ]
      },
      "1b50c697-4ab0-451c-890d-44ab109d04f4": {
        "akc_id": "1b50c697-4ab0-451c-890d-44ab109d04f4",
        "specimen": "92d9b519-9164-4997-aad8-7ef13bbcfb98",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_post-TRB-CLONE"
        ]
      },
      "9bb1ee3b-809d-41d7-91d5-e780bea86800": {
        "akc_id": "9bb1ee3b-809d-41d7-91d5-e780bea86800",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRA"
        ]
      },
      "efef0977-431b-4fe2-b916-978b24ef80f4": {
        "akc_id": "efef0977-431b-4fe2-b916-978b24ef80f4",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB"
        ]
      },
      "fb698a78-b890-4d33-939f-7f5a838c644f": {
        "akc_id": "fb698a78-b890-4d33-939f-7f5a838c644f",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-CELL"
        ]
      },
      "ce70b727-5feb-46a6-9c46-c854255c9d12": {
        "akc_id": "ce70b727-5feb-46a6-9c46-c854255c9d12",
        "specimen": "aae16c00-d11c-41a4-a00e-a3cc8189ad25",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre1-TRB-CLONE"
        ]
      },
      "958c43e1-d79a-46fc-a777-332be14713cc": {
        "akc_id": "958c43e1-d79a-46fc-a777-332be14713cc",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRA"
        ]
      },
      "68825c73-637c-408e-abf4-9ba628c135c5": {
        "akc_id": "68825c73-637c-408e-abf4-9ba628c135c5",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB"
        ]
      },
      "f53be836-cceb-45ee-8eb6-50d1ed38eaf9": {
        "akc_id": "f53be836-cceb-45ee-8eb6-50d1ed38eaf9",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-CELL"
        ]
      },
      "ca1c17d6-f2d8-4c46-827f-aeed74f9ed71": {
        "akc_id": "ca1c17d6-f2d8-4c46-827f-aeed74f9ed71",
        "specimen": "b6d90c5e-65c8-4613-b84f-2f7899988db4",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su001_pre2-TRB-CLONE"
        ]
      },
      "8eb7d2da-1ba6-448a-b4cc-5776efa02ff8": {
        "akc_id": "8eb7d2da-1ba6-448a-b4cc-5776efa02ff8",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRA"
        ]
      },
      "f3ecbe9b-7d21-477f-9919-3a600c76f59e": {
        "akc_id": "f3ecbe9b-7d21-477f-9919-3a600c76f59e",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB"
        ]
      },
      "66a5f3a4-51a9-42ef-8546-41062d7c4e51": {
        "akc_id": "66a5f3a4-51a9-42ef-8546-41062d7c4e51",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-CELL"
        ]
      },
      "f73d7990-c922-4e2c-b991-93cad54f7d38": {
        "akc_id": "f73d7990-c922-4e2c-b991-93cad54f7d38",
        "specimen": "55221162-6222-4812-83a1-692a57ff70cb",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_post-TRB-CLONE"
        ]
      },
      "eb6b4ba2-8f18-4e9c-9b83-351203daf69c": {
        "akc_id": "eb6b4ba2-8f18-4e9c-9b83-351203daf69c",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRA"
        ]
      },
      "d65a88ff-c7c0-4328-8e20-02305b1df34d": {
        "akc_id": "d65a88ff-c7c0-4328-8e20-02305b1df34d",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB"
        ]
      },
      "d00a99fd-69ea-4a36-83ae-bef5f845aeab": {
        "akc_id": "d00a99fd-69ea-4a36-83ae-bef5f845aeab",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-CELL"
        ]
      },
      "7df34d02-d21f-41d3-ac48-f19360e4bb42": {
        "akc_id": "7df34d02-d21f-41d3-ac48-f19360e4bb42",
        "specimen": "6f28ae14-4f4c-4a31-80a9-b3836a2c2df1",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su002_pre-TRB-CLONE"
        ]
      },
      "00422f59-9825-4478-a36f-0f0fd3acff87": {
        "akc_id": "00422f59-9825-4478-a36f-0f0fd3acff87",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRA"
        ]
      },
      "a391f80f-a660-4bab-9a26-1c49cdca83a0": {
        "akc_id": "a391f80f-a660-4bab-9a26-1c49cdca83a0",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB"
        ]
      },
      "6b7ca9b5-7795-4065-bbfa-963781a93d55": {
        "akc_id": "6b7ca9b5-7795-4065-bbfa-963781a93d55",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-CELL"
        ]
      },
      "7109417a-c127-4387-81b5-e0d13909b3a5": {
        "akc_id": "7109417a-c127-4387-81b5-e0d13909b3a5",
        "specimen": "7cbf2f3b-a809-45da-918e-442156b1094c",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_post-TRB-CLONE"
        ]
      },
      "4e05db22-636e-47fa-8fe7-7ca8e614959b": {
        "akc_id": "4e05db22-636e-47fa-8fe7-7ca8e614959b",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRA"
        ]
      },
      "6382f77e-bc33-4086-aa80-34c6fee9d846": {
        "akc_id": "6382f77e-bc33-4086-aa80-34c6fee9d846",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB"
        ]
      },
      "653a72f3-d92a-4739-ba29-8377efb88463": {
        "akc_id": "653a72f3-d92a-4739-ba29-8377efb88463",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-CELL"
        ]
      },
      "e927d920-7429-4f14-a70e-fded6d748e33": {
        "akc_id": "e927d920-7429-4f14-a70e-fded6d748e33",
        "specimen": "25b68ff4-3141-4407-8f0b-bae28b8c6c65",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su003_pre-TRB-CLONE"
        ]
      },
      "0dbe19df-4817-4469-8f9a-b685f89d8034": {
        "akc_id": "0dbe19df-4817-4469-8f9a-b685f89d8034",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRA"
        ]
      },
      "6a86a090-c118-4d30-8e56-cdc40303236b": {
        "akc_id": "6a86a090-c118-4d30-8e56-cdc40303236b",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB"
        ]
      },
      "aae75c35-0a4b-4492-9484-83d0cbd9f603": {
        "akc_id": "aae75c35-0a4b-4492-9484-83d0cbd9f603",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-CELL"
        ]
      },
      "d147f646-21a9-4774-9b30-3ef895200b15": {
        "akc_id": "d147f646-21a9-4774-9b30-3ef895200b15",
        "specimen": "71d5cca5-86d8-4500-bfb7-0f2ddff88b0d",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_post-TRB-CLONE"
        ]
      },
      "ef41a822-192e-4c28-83be-5e03466ced65": {
        "akc_id": "ef41a822-192e-4c28-83be-5e03466ced65",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRA"
        ]
      },
      "bb960874-8bb7-4468-9615-4de9bc60b5b1": {
        "akc_id": "bb960874-8bb7-4468-9615-4de9bc60b5b1",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB"
        ]
      },
      "aad23db0-78d8-49e1-b6f1-aac7a0e8477f": {
        "akc_id": "aad23db0-78d8-49e1-b6f1-aac7a0e8477f",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-CELL"
        ]
      },
      "1a5ca97e-1151-4334-a776-7b8cb205609f": {
        "akc_id": "1a5ca97e-1151-4334-a776-7b8cb205609f",
        "specimen": "038dad3c-51e4-4bce-ba89-19225bb007a6",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su004_pre-TRB-CLONE"
        ]
      },
      "34934adc-1cbd-4dab-a053-12c3a78b0fcc": {
        "akc_id": "34934adc-1cbd-4dab-a053-12c3a78b0fcc",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRA"
        ]
      },
      "003fa840-3cac-4377-bad8-fd4de27beb03": {
        "akc_id": "003fa840-3cac-4377-bad8-fd4de27beb03",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB"
        ]
      },
      "388aaee5-018c-4274-940c-2a3d2b332337": {
        "akc_id": "388aaee5-018c-4274-940c-2a3d2b332337",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-CELL"
        ]
      },
      "d129da0a-6f91-4e72-a2ea-c8f8f248f9b5": {
        "akc_id": "d129da0a-6f91-4e72-a2ea-c8f8f248f9b5",
        "specimen": "fd6f000b-1c5a-42a4-8c42-99d0d1abf20c",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_post-TRB-CLONE"
        ]
      },
      "6f867d88-8756-458f-b31f-75939b8eefd0": {
        "akc_id": "6f867d88-8756-458f-b31f-75939b8eefd0",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRA"
        ]
      },
      "640f1d5d-04fd-4a17-8ef0-f55df16c564e": {
        "akc_id": "640f1d5d-04fd-4a17-8ef0-f55df16c564e",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB"
        ]
      },
      "5a0aa911-05a4-45c0-a4ed-e186cab209c8": {
        "akc_id": "5a0aa911-05a4-45c0-a4ed-e186cab209c8",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-CELL"
        ]
      },
      "9350d440-4f2c-49ec-a4f7-7155c7ff5181": {
        "akc_id": "9350d440-4f2c-49ec-a4f7-7155c7ff5181",
        "specimen": "fba0fb98-21ab-4236-bc95-28afa9331d1b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su005_pre-TRB-CLONE"
        ]
      },
      "79de0aa9-115f-4343-9b23-fa35e3801f90": {
        "akc_id": "79de0aa9-115f-4343-9b23-fa35e3801f90",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRA"
        ]
      },
      "ca819637-432a-4c2c-9e79-deac273afb39": {
        "akc_id": "ca819637-432a-4c2c-9e79-deac273afb39",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB"
        ]
      },
      "893b1f3d-c916-456f-bbc7-de2d4c01ceff": {
        "akc_id": "893b1f3d-c916-456f-bbc7-de2d4c01ceff",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-CELL"
        ]
      },
      "fb918c50-1271-43c1-9782-77d5d06896b1": {
        "akc_id": "fb918c50-1271-43c1-9782-77d5d06896b1",
        "specimen": "78a36f69-1d49-4b0f-bcb9-d844669e53de",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_post-TRB-CLONE"
        ]
      },
      "05581d65-18b9-4644-b9e4-7fb14119f349": {
        "akc_id": "05581d65-18b9-4644-b9e4-7fb14119f349",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRA"
        ]
      },
      "b17ec252-2d6e-4c46-9be4-16f6454cd450": {
        "akc_id": "b17ec252-2d6e-4c46-9be4-16f6454cd450",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB"
        ]
      },
      "d7ecadb9-b179-4c99-ad29-9b9bfc3bc92d": {
        "akc_id": "d7ecadb9-b179-4c99-ad29-9b9bfc3bc92d",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-CELL"
        ]
      },
      "98a0dbd4-9e87-475d-968c-7df74d521469": {
        "akc_id": "98a0dbd4-9e87-475d-968c-7df74d521469",
        "specimen": "435f4efc-51ae-4755-b910-96b229feed70",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su006_pre-TRB-CLONE"
        ]
      },
      "11d5e52d-2b1b-464c-9adf-c26eceb37478": {
        "akc_id": "11d5e52d-2b1b-464c-9adf-c26eceb37478",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRA"
        ]
      },
      "83a041c4-a6e1-4ee1-87f3-39f47e80335d": {
        "akc_id": "83a041c4-a6e1-4ee1-87f3-39f47e80335d",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB"
        ]
      },
      "b066afc1-e0ca-4de9-84c0-7f5587955593": {
        "akc_id": "b066afc1-e0ca-4de9-84c0-7f5587955593",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-CELL"
        ]
      },
      "ce17e6da-ff06-4445-af56-9079ef1322e3": {
        "akc_id": "ce17e6da-ff06-4445-af56-9079ef1322e3",
        "specimen": "a6596eb2-9c22-4362-8d40-148f6a92eb77",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_post-TRB-CLONE"
        ]
      },
      "fe26404d-ff97-4204-98e1-dcb15b97cb42": {
        "akc_id": "fe26404d-ff97-4204-98e1-dcb15b97cb42",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRA"
        ]
      },
      "c60c7bde-4e59-49b2-b023-b780eb6b0917": {
        "akc_id": "c60c7bde-4e59-49b2-b023-b780eb6b0917",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB"
        ]
      },
      "06ee50bf-77c8-4dc5-8143-6eea141e026b": {
        "akc_id": "06ee50bf-77c8-4dc5-8143-6eea141e026b",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-CELL"
        ]
      },
      "f8fa3f94-9fc8-4a7b-bbe4-af703fad8538": {
        "akc_id": "f8fa3f94-9fc8-4a7b-bbe4-af703fad8538",
        "specimen": "d77b4c8b-abfc-4fc8-a521-cc73e8118bb5",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su007_pre-TRB-CLONE"
        ]
      },
      "02e3e3dc-ac0d-4a69-be58-29f1022aa2e4": {
        "akc_id": "02e3e3dc-ac0d-4a69-be58-29f1022aa2e4",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRA"
        ]
      },
      "232c5f78-b31d-467b-8ca4-4431d23627cc": {
        "akc_id": "232c5f78-b31d-467b-8ca4-4431d23627cc",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB"
        ]
      },
      "4262cdab-ac67-491c-88e1-5da27bee86fb": {
        "akc_id": "4262cdab-ac67-491c-88e1-5da27bee86fb",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-CELL"
        ]
      },
      "a8609797-be16-4313-83cf-4f25cd519c8e": {
        "akc_id": "a8609797-be16-4313-83cf-4f25cd519c8e",
        "specimen": "d9067d60-21f3-4026-9eca-757b3ce3ef6b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_post-TRB-CLONE"
        ]
      },
      "df75a336-99df-474a-9501-a3264d8215ee": {
        "akc_id": "df75a336-99df-474a-9501-a3264d8215ee",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRA"
        ]
      },
      "f3d783d7-2547-496b-9ea5-5ebdf72ef9bd": {
        "akc_id": "f3d783d7-2547-496b-9ea5-5ebdf72ef9bd",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB"
        ]
      },
      "23b3943d-ca31-41eb-bddb-754a6569c1bb": {
        "akc_id": "23b3943d-ca31-41eb-bddb-754a6569c1bb",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-CELL"
        ]
      },
      "0cf5189f-a218-440f-90d5-ff2cfdf28dba": {
        "akc_id": "0cf5189f-a218-440f-90d5-ff2cfdf28dba",
        "specimen": "1c2493af-1e3f-462e-93a5-fbd8030c9aec",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su008_pre-TRB-CLONE"
        ]
      },
      "db558501-855e-4381-ba5b-c21fb5525819": {
        "akc_id": "db558501-855e-4381-ba5b-c21fb5525819",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRA"
        ]
      },
      "abbff084-7f7a-45b8-b11e-d2cb97eca210": {
        "akc_id": "abbff084-7f7a-45b8-b11e-d2cb97eca210",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB"
        ]
      },
      "db43d085-e3cc-4f71-b996-bfb5aca5ec9a": {
        "akc_id": "db43d085-e3cc-4f71-b996-bfb5aca5ec9a",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-CELL"
        ]
      },
      "f7e351e0-a231-4da3-afb1-80da1f911520": {
        "akc_id": "f7e351e0-a231-4da3-afb1-80da1f911520",
        "specimen": "5b27e569-e307-45c9-bee6-84d7d695790c",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_post-TRB-CLONE"
        ]
      },
      "b380aa07-b2ae-4c7b-9c5f-083463fe6e4c": {
        "akc_id": "b380aa07-b2ae-4c7b-9c5f-083463fe6e4c",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRA"
        ]
      },
      "5a98ca4a-9149-4dfc-acb5-f157738b7206": {
        "akc_id": "5a98ca4a-9149-4dfc-acb5-f157738b7206",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB"
        ]
      },
      "6c4faa8f-ca7b-41c5-9568-89bdd5493b85": {
        "akc_id": "6c4faa8f-ca7b-41c5-9568-89bdd5493b85",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-CELL"
        ]
      },
      "7aafb7db-6994-40f8-8fad-c90c302736d6": {
        "akc_id": "7aafb7db-6994-40f8-8fad-c90c302736d6",
        "specimen": "c46e236c-65de-41a2-9b46-4aa67163e957",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su009_pre-TRB-CLONE"
        ]
      },
      "01f67e22-ffb2-4983-aa47-c4691a4a2a3a": {
        "akc_id": "01f67e22-ffb2-4983-aa47-c4691a4a2a3a",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRA"
        ]
      },
      "67dc3e29-6fa2-449c-a4c7-bcd7793f3bd9": {
        "akc_id": "67dc3e29-6fa2-449c-a4c7-bcd7793f3bd9",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB"
        ]
      },
      "c377d498-02ab-4d5b-a17d-0380dae76e82": {
        "akc_id": "c377d498-02ab-4d5b-a17d-0380dae76e82",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-CELL"
        ]
      },
      "94674cd1-69c3-41a2-9c05-35ae716fb118": {
        "akc_id": "94674cd1-69c3-41a2-9c05-35ae716fb118",
        "specimen": "e2aba60b-1a13-4605-a3b5-b767aba262b0",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_BCC-TRB-CLONE"
        ]
      },
      "b240d624-28b4-4244-89f8-a005f07a56ac": {
        "akc_id": "b240d624-28b4-4244-89f8-a005f07a56ac",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRA"
        ]
      },
      "ff74c937-10fe-4f73-b1ba-1686c2db1389": {
        "akc_id": "ff74c937-10fe-4f73-b1ba-1686c2db1389",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB"
        ]
      },
      "87c48a0e-881d-4fd2-9127-a79b4687d164": {
        "akc_id": "87c48a0e-881d-4fd2-9127-a79b4687d164",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-CELL"
        ]
      },
      "5e91a76f-0868-412d-b8f5-61d04c893244": {
        "akc_id": "5e91a76f-0868-412d-b8f5-61d04c893244",
        "specimen": "25548f5a-485c-48f8-a86e-fb3a91f48302",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC-TRB-CLONE"
        ]
      },
      "ef5a5840-5653-4e64-9097-ab6db920e975": {
        "akc_id": "ef5a5840-5653-4e64-9097-ab6db920e975",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRA"
        ]
      },
      "abde37e0-be0a-4da9-9810-d5f6fa015b1a": {
        "akc_id": "abde37e0-be0a-4da9-9810-d5f6fa015b1a",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB"
        ]
      },
      "d6bc7b13-c581-4921-91b8-2c4db254cd6f": {
        "akc_id": "d6bc7b13-c581-4921-91b8-2c4db254cd6f",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-CELL"
        ]
      },
      "cb4d6889-bc6a-4d4b-ae99-b1e9dfa5b48f": {
        "akc_id": "cb4d6889-bc6a-4d4b-ae99-b1e9dfa5b48f",
        "specimen": "b79ab136-1b28-43df-8127-f010833c0ad7",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_post_SCC_CD39-TRB-CLONE"
        ]
      },
      "dfa26ecb-b72d-4805-b216-df8086bbc127": {
        "akc_id": "dfa26ecb-b72d-4805-b216-df8086bbc127",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRA"
        ]
      },
      "74142492-47fa-4827-9874-d44c47a82d90": {
        "akc_id": "74142492-47fa-4827-9874-d44c47a82d90",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB"
        ]
      },
      "2770f392-7c90-4ca2-9304-8c7ed45256e2": {
        "akc_id": "2770f392-7c90-4ca2-9304-8c7ed45256e2",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-CELL"
        ]
      },
      "8663cae6-7f35-49a8-8177-2fa25047d7f4": {
        "akc_id": "8663cae6-7f35-49a8-8177-2fa25047d7f4",
        "specimen": "914281f3-349e-49ed-ad79-b936ffb285a0",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_BCC-TRB-CLONE"
        ]
      },
      "03e695fa-b1e0-4f57-bb6a-24b9ceb06b61": {
        "akc_id": "03e695fa-b1e0-4f57-bb6a-24b9ceb06b61",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRA"
        ]
      },
      "5bf1822c-fa7c-45ee-8716-d0bde1d2365c": {
        "akc_id": "5bf1822c-fa7c-45ee-8716-d0bde1d2365c",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB"
        ]
      },
      "4d20a8de-a680-43d4-b5d3-61f4d7adc863": {
        "akc_id": "4d20a8de-a680-43d4-b5d3-61f4d7adc863",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-CELL"
        ]
      },
      "c230890d-c9b7-4b7e-8aea-112d74b2b6f4": {
        "akc_id": "c230890d-c9b7-4b7e-8aea-112d74b2b6f4",
        "specimen": "a83c23f7-8f17-4c8e-acf6-b398c68b7fbc",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep1-TRB-CLONE"
        ]
      },
      "e31effac-20df-417a-bae7-ddb691ed1b74": {
        "akc_id": "e31effac-20df-417a-bae7-ddb691ed1b74",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRA"
        ]
      },
      "e6cc12e7-22dc-4e29-af7a-7fce1e9a8b07": {
        "akc_id": "e6cc12e7-22dc-4e29-af7a-7fce1e9a8b07",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB"
        ]
      },
      "45e7ae3e-d851-4e59-9c16-64f771a44df0": {
        "akc_id": "45e7ae3e-d851-4e59-9c16-64f771a44df0",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-CELL"
        ]
      },
      "d7bb9160-5cea-41e9-9cdf-09635acdd34c": {
        "akc_id": "d7bb9160-5cea-41e9-9cdf-09635acdd34c",
        "specimen": "29b69431-9d47-452d-a6b0-dd5d570368d9",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su010_pre_SCC_rep2-TRB-CLONE"
        ]
      },
      "0eb09d2a-13c3-458e-bd02-501f9d58feb1": {
        "akc_id": "0eb09d2a-13c3-458e-bd02-501f9d58feb1",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRA"
        ]
      },
      "bef67eff-c1e9-48d5-8342-98ca2f9efac6": {
        "akc_id": "bef67eff-c1e9-48d5-8342-98ca2f9efac6",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB"
        ]
      },
      "31fe33a9-e2d6-485d-896e-020c581c0910": {
        "akc_id": "31fe33a9-e2d6-485d-896e-020c581c0910",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-CELL"
        ]
      },
      "33cac73e-23a3-4e1a-aea6-53752ac51bd5": {
        "akc_id": "33cac73e-23a3-4e1a-aea6-53752ac51bd5",
        "specimen": "a3605308-9342-4be1-be8c-d090d4c0cf1b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_post-TRB-CLONE"
        ]
      },
      "26975e5b-7c14-41f1-80c0-c1510c445362": {
        "akc_id": "26975e5b-7c14-41f1-80c0-c1510c445362",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRA"
        ]
      },
      "d21d2476-543b-45af-b051-43f6435ced65": {
        "akc_id": "d21d2476-543b-45af-b051-43f6435ced65",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB"
        ]
      },
      "5a60bbf9-211a-4f8e-868a-8680aaf80cdd": {
        "akc_id": "5a60bbf9-211a-4f8e-868a-8680aaf80cdd",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-CELL"
        ]
      },
      "dbcb29d4-de67-494a-918a-09542f3a58fc": {
        "akc_id": "dbcb29d4-de67-494a-918a-09542f3a58fc",
        "specimen": "7d5e6a0d-5e2e-4c7c-9039-dce172c75376",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep1-TRB-CLONE"
        ]
      },
      "c932980c-ded1-4fb4-89d8-1a1d13f443c1": {
        "akc_id": "c932980c-ded1-4fb4-89d8-1a1d13f443c1",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRA"
        ]
      },
      "9229ac7f-ba92-4cfd-b1ad-3ff4201f5400": {
        "akc_id": "9229ac7f-ba92-4cfd-b1ad-3ff4201f5400",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB"
        ]
      },
      "cf47cecb-299e-4d2c-a75a-f30fefd3c1fe": {
        "akc_id": "cf47cecb-299e-4d2c-a75a-f30fefd3c1fe",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-CELL"
        ]
      },
      "7239c918-5dcf-4d4b-9566-518a76036066": {
        "akc_id": "7239c918-5dcf-4d4b-9566-518a76036066",
        "specimen": "8a1f1002-8b38-4053-a203-73af2cf7c499",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su011_pre_rep2-TRB-CLONE"
        ]
      },
      "997bb76f-3f99-4b6d-aa94-a45a6efe58d4": {
        "akc_id": "997bb76f-3f99-4b6d-aa94-a45a6efe58d4",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRA"
        ]
      },
      "a5ad5264-cd6a-4b13-aee5-fb2b001f3eac": {
        "akc_id": "a5ad5264-cd6a-4b13-aee5-fb2b001f3eac",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB"
        ]
      },
      "ebddc6f2-cc8c-4cb5-9761-848349ac1daa": {
        "akc_id": "ebddc6f2-cc8c-4cb5-9761-848349ac1daa",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-CELL"
        ]
      },
      "2c241b57-b90c-4c7d-b7e1-659e38b8967e": {
        "akc_id": "2c241b57-b90c-4c7d-b7e1-659e38b8967e",
        "specimen": "119b69ad-ea8f-4145-8211-71eccbbcde4b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_post-TRB-CLONE"
        ]
      },
      "0b47e2f6-b3ee-44a8-85d3-6b287ab7f0fd": {
        "akc_id": "0b47e2f6-b3ee-44a8-85d3-6b287ab7f0fd",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRA"
        ]
      },
      "7edbfa0c-1b5b-426c-b94d-bb26f35f62f5": {
        "akc_id": "7edbfa0c-1b5b-426c-b94d-bb26f35f62f5",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB"
        ]
      },
      "b49ae668-41eb-45a0-9571-7f945c99b7da": {
        "akc_id": "b49ae668-41eb-45a0-9571-7f945c99b7da",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-CELL"
        ]
      },
      "580e6a97-4c92-4098-8cf7-0d69035a7885": {
        "akc_id": "580e6a97-4c92-4098-8cf7-0d69035a7885",
        "specimen": "7d1b34f2-cb4d-4e5c-b60e-b0cac622213d",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su012_pre-TRB-CLONE"
        ]
      },
      "639ab9ca-3533-4e4c-bebc-05131597cf12": {
        "akc_id": "639ab9ca-3533-4e4c-bebc-05131597cf12",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRA"
        ]
      },
      "ef803337-42c6-4156-a031-751edea98b76": {
        "akc_id": "ef803337-42c6-4156-a031-751edea98b76",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB"
        ]
      },
      "6dea779c-faf6-4083-b204-a633f8a20937": {
        "akc_id": "6dea779c-faf6-4083-b204-a633f8a20937",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-CELL"
        ]
      },
      "d228b810-fc9c-453c-ac9b-cc5fa3ef8a8c": {
        "akc_id": "d228b810-fc9c-453c-ac9b-cc5fa3ef8a8c",
        "specimen": "098f12b0-f535-45d9-a248-af22f3cddd5b",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_post-TRB-CLONE"
        ]
      },
      "780ae15a-ff05-4e59-9e1d-b8d303ca2385": {
        "akc_id": "780ae15a-ff05-4e59-9e1d-b8d303ca2385",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRA"
        ]
      },
      "3e289901-1aa3-4ae2-aad5-2b144f28d13b": {
        "akc_id": "3e289901-1aa3-4ae2-aad5-2b144f28d13b",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB"
        ]
      },
      "933e371b-18d2-41dc-a9c1-9e9d2004c1b0": {
        "akc_id": "933e371b-18d2-41dc-a9c1-9e9d2004c1b0",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-CELL"
        ]
      },
      "6ed40141-20a2-4b87-9ba3-46500428cd94": {
        "akc_id": "6ed40141-20a2-4b87-9ba3-46500428cd94",
        "specimen": "cebbf35a-4838-4001-b9af-27f3da23ab76",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su013_pre-TRB-CLONE"
        ]
      },
      "429b2bda-6f0f-4b88-ae93-c5ee1ef0a68f": {
        "akc_id": "429b2bda-6f0f-4b88-ae93-c5ee1ef0a68f",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRA"
        ]
      },
      "4ce69db6-95bd-4142-8bef-59d9a909599b": {
        "akc_id": "4ce69db6-95bd-4142-8bef-59d9a909599b",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB"
        ]
      },
      "781d722c-4800-4e7b-9044-b551bd2a7a85": {
        "akc_id": "781d722c-4800-4e7b-9044-b551bd2a7a85",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-CELL"
        ]
      },
      "7ddb82f9-db9a-456c-a81d-6bb998c85256": {
        "akc_id": "7ddb82f9-db9a-456c-a81d-6bb998c85256",
        "specimen": "8775cdd8-827c-46c9-b205-76f530f9bcf2",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_post-TRB-CLONE"
        ]
      },
      "cb5210bd-bc8d-48be-973f-d7a66a96efec": {
        "akc_id": "cb5210bd-bc8d-48be-973f-d7a66a96efec",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRA"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRA"
        ]
      },
      "4a16dff6-04a6-4b6a-9c60-fbfc902c6329": {
        "akc_id": "4a16dff6-04a6-4b6a-9c60-fbfc902c6329",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB"
        ]
      },
      "eb16660e-4a9c-4689-b4b9-2f9935916141": {
        "akc_id": "eb16660e-4a9c-4689-b4b9-2f9935916141",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "type": "ReceptorRepertoireSequencingAssay",
        "complete_sequences": "partial",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-CELL"
        ]
      },
      "ea745d3c-2453-4cfa-96c5-25d199175a25": {
        "akc_id": "ea745d3c-2453-4cfa-96c5-25d199175a25",
        "specimen": "b20f015a-51d4-4cee-956e-25af251e44bc",
        "type": "ReceptorRepertoireSequencingAssay",
        "pcr_target": [
          "TRB"
        ],
        "complete_sequences": "complete+untemplated",
        "physical_linkage": "nan",
        "source_uris": [
          "ADC_REPERTOIRE:PRJNA509910-su014_pre-TRB-CLONE"
        ]
      }
    }
  },
  "@type": "dict"
}
